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The human brain is complex. Its complexity is beyond the threshold required for self-contemplation,
and thus, its marvels have intrigued scientists for millennia. In the words of the great Russian-
American geneticist Theodosius Dobzhansky:1
"In giving rise to man, the evolutionary process has, apparently for the ﬁrst and only time in the
history of the Cosmos, become conscious of itself." [1]
Brain tissue is vulnerable. High intracranial pressure (ICP) is a feared common endpoint of
many conditions that cause extensive brain tissue damage, and it is characterized by expansive
processes such as tumours or accumulation of ﬂuid inside the cranium. The ﬂuid in question
can be blood, cerebrospinal ﬂuid or interstitial ﬂuid. Whatever the cause, high ICP produces
symptoms ranging from fairly unpleasant headaches to sudden death. At some point in ancient
surgical history, it was established that a practical way to treat high pressure is to lower it.
Archeological ﬁndings reveal that the ﬁrst attempts on curing headaches by trepanation, the act
of drilling a hole in the skull, took place in the Middle East at the time of the Neolithic Period,
9500 years BC [2]. Modern medicine has subsequently progressed for almost twelve thousand
years, but craniectomy, removal of a part of the skull, is still regarded as an important treatment
in severe cases of high ICP. Today, if the cause of high ICP can not be rapidly reversed, treatment
options include osmotic diuresis with mannitol, glucocorticoids, hyperventilation, barbiturates,
drainage of cerebrospinal ﬂuid, and as a last resort, a craniectomy. Neuroscientists have long
had a notion that there are likely other treatment options to be found, more sophisticated and
gentle than merely drilling a hole in the skull to relieve pressure. To discover such potential new
therapies, one must ﬁrst know the mechanisms involved in development of high ICP in more
detail.
Brain ﬂuid dynamics as a research ﬁeld attracts a broad range of scientiﬁc disciplines such as
neurosurgery, neurology, intensive medicine, traumatology and basic neuroscience. This large
volume of research activity underlines the crucial role of ﬂuid transport in the pathophysiology
of major brain diseases.
The brain is dependent on a stable metabolic state for optimal function. Minute deviations
from the metabolic equilibrium aﬀect the extracellular environment of neurons. As their cell
1Theodosius Grygorovych Dobzhansky (1900-1975) was a prominent geneticist and evolutionary biologist, and
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Chapter 1. Introduction Central nervous system (CNS) ﬂuid dynamics
1.3 Central nervous system (CNS) ﬂuid dynamics
1.3.1 Macroscopic level
Water accounts for 80% of the brain mass [5]. Proper circulation of water is essential for normal
brain function. Brain water is distributed among four major ﬂuid compartments: blood, CSF,
interstitial ﬂuid (ISF), and intracellular ﬂuid (ICF). Water moves among these compartments to
maintain homeostasis, though the compartments are not all interconnected (Figure 1.1, below). It










Figure 1.1: Overview of ﬂuid compartments in the central nervous system (CNS). Water (blue
arrows) moves freely between adjacent compartments following osmotic and hydrostatic gradi-
ents, except when barriers are present. Blood is separated from CSF by the blood-CSF barrier
(BCB) and from ISF by the blood-brain barrier (BBB). These are selective barriers that limit
the transport of water and solutes between compartments. G. A. Gundersen.
The ﬂuid is not equally distributed among the compartments, as seen when comparing volume
fractions as share of total brain volume (Figure 1.2 on the following page). The interfaces between
diﬀerent ﬂuid compartments have variable permeability to water and osmotically active solutes,
and thus act as selective barriers [7]. Water crosses these barriers through diﬀerent mechanisms,
which will be discussed in more detail in section 1.4.2. In the following section we will give a
brief introduction to the four ﬂuid compartments.
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Figure 1.2: Schematic illustrating the volume fractions of the main ﬂuid compartments of the
brain as share of total brain volume. Blood vessels (red), 3% [8], cerebrospinal ﬂuid (CSF) (grey),
2% [9], interstitial ﬂuid (ISF) (blue), 20-25% [8, 10], and intracellular ﬂuid (ICF) (white), 70%.
G. A. Gundersen.
1.3.1.1 Blood
Blood vessels are estimated to constitute 3% of total brain volume [8]. Blood enters the cra-
nial cavity through the major internal carotid arteries and the vertebral arteries. The arteries
interconnect at the base of the brain and then branch out on the surface of the brain, sending
penetrating arteries and smaller arterioles perpendicularly into the brain parenchyma [11]. In
the parenchyma, hair-thin capillaries supply the brain cells and exchange nutrients for metabolic
waste products. Venules and veins drain the blood to wide venous sinuses emptying into the
jugular veins and returning blood to the systemic circulation [11]. The total cerebral blood vol-




Figure 1.3: Schematic illustrating the volume fractions of the diﬀerent blood vessel subtypes
as share of total cerebral blood volume (CBV). Arteries (red), 30% [12, 13], capillaries (grey)
2% [14], and veins (blue), 68% [12]. G. A. Gundersen.
Water does not move freely from blood to CSF or from blood to interstitial space [7]. The blood-
4
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CSF barrier and the BBB (see 1.4 on page 9) are anatomical and physiological barriers which
control the passage of molecules between compartments in a highly regulated fashion [15]. An
important function of these barriers is to protect the brain parenchyma from major ﬂuctuations
in blood constituents.
1.3.1.2 CSF - the "lymphatic system" of the brain
All metabolically active tissue needs to dispose of waste products. Waste products and surplus
water that do not enter the venous blood circulation for transportation accumulate in the inter-
stitial ﬂuid. This surplus ﬂuid is what constitutes the lymph in the majority of the body. The
lymphatic system is a network of vessels and part of the circulatory system [16]. It acts as a
sewer, its main purpose being drainage of surplus interstitial ﬂuid containing metabolic waste
products from peripheral tissue to the central parts of the body [17,18]. Ultimately the lymphatic
ﬂuid empties into the great caval veins close to the heart [17]. The only part of the body without
lymphatic vessels is the cranial cavity, in which the brain resides. This is puzzling. The brain
is an organ of high metabolic rate and energy consumption, receiving 15% of the cardiac output
of blood, with a commensurate output of waste and metabolic byproducts. Lacking lymphatic
vessels, another mechanism must be in place to perform the lymphatic function, and the widely
accepted theory is that the system in question is the cerebrospinal ﬂuid [19].
CSF contains glucose, proteins, electrolytes and other solutes in concentrations speciﬁc for the
CSF, but no cells. It is primarily produced by the choroid plexus in the ventricles in central
areas of the brain, at a rate of about half a liter per day [20]. A CT-study in humans esti-
mated the average volume fraction of the ventricles to be 2% of total brain volume [9]. CSF
exits the ventricle systems through three holes in the ceiling of the fourth ventricle and enters
subarachnoid space. Here it is distributed outside the pial surface of the brain and spinal cord.
It is subsequently drained out of the subarachnoid space through small one-way valves called
arachnoid granulations to the sinus venosus and the venous system [21], and also into peripheral
lymphatic system through the cribriform plate .
1.3.1.3 Interstitial ﬂuid
When substances diﬀuse in the brain, they move mainly through the ECS, which separates one
cell membrane from the other. The volume fraction (α) of the ECS is the volume occupied by
the ECS as share of total brain volume, expressed as:
α = VECS/VTissue
Studies in rats have shown that ECS volume fraction is signiﬁcantly reduced from postnatal
day 2 (40%) to postnatal day 21 (20%) [10]. The volume fraction is generally accepted to be
between 15 and 30% in the adult brain, typically being 20% and falling to 5% during global
ischemia [8]. It is harder to determine the true size of the ECS between individual cells, and the
volume varies across regions [8]. A study using nanocrystals estimated the true average width of
ECS in the in vivo rat brain to be between 38 and 64 nm [22]. The ISF is the ﬂuid component
of the ECS, enabling nervous tissue cells to engage in a constant exchange of water, electrolytes
and metabolites. ISF composition is believed to be similar to the CSF, but in contrast to CSF,
direct assay of the ISF is not achievable because of the lack of compartments of suﬃcient size
5
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to sample from. The ISF is important for several reasons. It enables neurons to perform stable
electrical signalling by acting as a reservoir for extracellular ions. It also acts as a conduit for
substances moving from cells to the blood. Microscopy studies indicate that the average distance
from a neuron to the nearest adjacent blood vessel is about 20 μm [23]. Source of production
of ISF is not entirely understood, but the ﬂuid is derived both from blood and CSF from the
ventricles [15].
Computer models have been used to simulate the movement trajectories of substances moving
randomly in an idealised ECS, between the convex surfaces of individual cells. The models have
shown that the ECS allows spreading of substances by diﬀusion [8]. The same authors suggest
at least ﬁve factors aﬀecting the diﬀusion of molecules in the ECS; the geometry of ECS delays
diﬀusion compared to a free medium, dead-space microdomains delay molecules by enabling
them to explore a dead end, diﬀusing molecules are physically obstructed by extracellular matrix
molecules, binding sites for the diﬀusing molecule on adjacent cell membranes or extracellular
matrix proteins slow down diﬀusion, and ﬁxed negative charges, e.g. on extracellular matrix
proteins can aﬀect the diﬀusion of charged molecules [8]. To be able to predict the distribution
of a substance, one has to know the diﬀusion coeﬃcient in neuronal tissue and the relative
importance of this diﬀusion versus other clearance mechanisms for the particular substance.
When considering nervous tissues, the term tortuosity (λ) is often used to characterize the
observed diﬀusion hindrance. Tortuosity is deﬁned as the square root of the following ratio: the
diﬀusion coeﬃcient in a free medium (D) divided by the observed diﬀusion coeﬃcient in the




The concept of tortuosity is useful when considering diﬀusion of both solutes and water in the
ECS. Bulk ﬂow of ISF through the ECS has been hypothesized, but it is unclear how important
this mode of water distribution is relative to diﬀusion. Clearance of ISF has been proposed to
occur via three major routes, either across the BBB to the blood stream, across the ependymal
cells to the ventricles or across the pial surface to the subarachnoid space [6]. As all blood vessels
and the pial surface are almost completely covered by a sheet of glial cell processes [24], all the
three exit routes require water transport across interfaces covered by glia (astrocytic endfeet,
ependymal cells) that express AQP4 [6].
1.3.1.4 Intracellular ﬂuid
The ICF of the CNS is located within each individual nervous tissue cell in a closed compartment,
with no communication to the ECS except through cell membranes. The cell precisely regulates
the content of the ICF by active and passive transportation of molecules across the cell membrane,
exchanging substances with the ISF. The ICF composition diﬀers both across CNS cell types and
within any individual cell. In a typical eukaryotic cell, about 70% of the cell volume is cytosol,
while the rest is made up by diﬀerent organelles [25]. The cytosol consists mostly of water,
dissolved ions like potassium, sodium and chloride, small molecules, and large water-soluble
molecules like proteins (Table 1.1 on the next page).
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Amino acids in proteins 138 9
Magnesium 0.8 1.5
Calcium <0.0002 1.8
Table 1.1: Ion concentrations diﬀer between intracellular and interstitial ﬂuid. Gradients are
maintained by active transporter molecules. Source: Molecular Cell Biology, Lodish et al (2000)
[26].
The diﬀerent ICF and ISF ion concentrations create ion gradients between the interior and exte-
rior of the cell. The ion gradients are continuously maintained by active and passive ion transport
mechanisms as well as by co-transport of ions and other solutes. The Na+/K+-ATPase is an
active transporter that maintains a negative cell membrane potential by pumping sodium out
of and potassium into the cell. Potassium then leaks out following its concentration gradient
through potassium-speciﬁc ion channels. This leakage of potassium creates a electric potential
diﬀerence across the cell membrane, being slightly more positive on the outside of the cell. The
gradients serve several purposes, such as maintaining an electric membrane potential required
for neuronal signalling. The gradient of sodium ions enables transport of speciﬁc solutes such as
glutamate across the cell membrane against glutamate’s concentration gradients by co-transport
with sodium ions following their electrochemical gradient. Water, being a relatively small and
polar molecule, crosses the cell membrane both by diﬀusion through the lipid bilayer, by fol-
lowing other molecules through their designated transporter proteins, and by transport through
aquaporins (see 1.4.2 on page 21) [27].
1.3.2 Synaptic level
When zooming in from the four macro-level ﬂuid compartments to the micro-level of an individual
synapse, we can observe ﬂuid shifts in more detail. Thirty years ago it was observed that the
extracellular volume is subject to rapid changes, the driver being synaptic activation [28]. When
a synapse is active, the ECS and the intracellular compartments of the synapse’s constituent
cells undergo reversible volume changes [29]. Using membrane impermeant cations, extracellular
space volume reductions in the range of 5 to 30% were observed after high frequency activation of
excitatory pathways [8]. The volume changes are assumed to be caused by water redistribution
due to ion ﬂuxes between compartments [8,29]. While the mechanism of these dynamic changes
remains to be explained in detail, it is now assumed that they reﬂect water cotransport coupled
to rapid uptake of ions and transmitters in perisynaptic glial cells [30, 31].
Water cotransport has been documented for a number of ions and transmitters, including K+,
bicarbonate, and glutamate [30]. The exact contribution to this water shift by the diﬀerent ion-
channels and -transporters is not known. Several independent studies the last forty years have
shown that perisynaptic glial cells swell as function of extracellular K+ concentration [31]. This
K+-induced swelling response in cortical cells correlates linearly with a K+-induced intracellular
accumulation of chloride-ions, suggesting K+-dependent chloride inﬂux as the mechanism un-
derlying the observed swelling [31]. Interestingly, pharmacological inhibition or genetic deletion
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of the Na+/K+/2Cl− cotransporter (NKCC1) eliminates the K+-induced swelling response in
cultured astrocytes [32,33].
The Na+-dependent glutamate transporter-1 (EAAT1) is located in perisynaptic glial mem-
branes and are important for clearing the ECS of glutamate after synaptic activity. Glutamate
is toxic to neurons, and thus rapid clearance of glutamate from the ECS after synaptic release
is neuroprotective. EAAT1 is a cotransporter, driving glutamate into the glial cell against its
electrochemical gradient by cotransportation with H+ and Na+, the latter following its electro-
chemical gradient, in exchange for K+. This way glutamate is transported into glial cells, adding
to the swelling response by favouring movement of water into the cell [30]. One study showed
that addition of glutamate to astrocytes in culture increased glial swelling in a concentration-
dependent fashion. The authors added diﬀerent concentrations of glutamate (5μM to 50mM)
to the culture and observed average swelling increases ranging from 5 to 18%, respectively [34].
The roles of the water channel AQP4 in regulation of perisynaptic ECS-volume will be described
in more detail in section 1.6.2 on page 26.
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1.4 The blood-brain barrier and water ﬂux
1.4.1 Anatomy of the BBB
To understand water transport between compartments on the level of capillary blood vessels
we must understand the cellular layers that water penetrates. In 1885, the German physician,
hematologist, and scientist Paul Ehrlich injected a dye intravenously and discovered that all
organs were colored except the brain and the spinal cord [35]. Three decades later Edwin
Goldmann, one of Ehrlich’s students, observed that brain tissue was colored if the same dye
was injected directly into the CSF, but in this case the rest of the body was not [36]. The
conclusion was that a barrier must exist, separating the two metabolic compartments blood and



















Figure 1.4: Overview of anatomical layers of the BBB. Lining the capillary lumen is the endothe-
lial cell (blue), covered by its basal lamina (grey). The astrocytic endfoot (green) separates the
basal lamina from brain neurons. Pericytes (red) are interposed between the endothelium and the
astrocytic processes. Tight junctions between endothelial cells prevent paracellular transport.
Water, glucose, amino acids and electrolytes have transporter proteins in the cell membranes.
Gases and small, polar molecules diﬀuse across the phospholipid bilayers of the cell membranes.
G. A. Gundersen.
The BBB is a conceptual and functional barrier, not a localized physical one. The anatomical
substrate of the BBB in mammals is made up of four main components. Moving from blood to
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brain, the four components of the BBB are the endothelial cells, the basal lamina, the pericytes
and the astrocytes (Figure 1.4 on the preceding page). Some authors do not consider astrocytes
as part of the BBB, presumably because they are by deﬁnition a CNS cell type, and because the
BBB is a functional barrier in which the astrocyte is generally considered a minor contributor.
In this case the endothelial cells, pericytes, and basal lamina together with adjacent astrocytes,
neurons, and possibly other glial cells, are often collectively referred to as the "neurovascular
unit". To clarify, we choose to treat astrocytes as part of the BBB, given that they have been
shown to regulate barrier function. Pericytes are not always present between the basal lamina
and the astrocyte (see 1.4.1.3 on the next page).
These four BBB components do not contribute equally to the barrier function, and have changed
evolutionary over time. Studies on extant vertebrates showed that 4-500 million years ago,
the BBB barrier function of all vertebrates was primarily in the glial cells [37]. Today, in
elasmobranches, a subclass of cartilaginous ﬁsh including sharks, rays and skates, the barrier
function is still primarily in the glial endfeet [38,39].
As will be clear in the following sections, barrier function in modern mammals lies primarily
in the endothelial component of the BBB. The development of an endothelial barrier seems to
have arisen several times independently in the course of evolution, indicating that an endothelial
barrier provides strong selective advantage [37]. On that note, several serious diseases are accom-
panied by disruption of the BBB, such as brain tumours, multiple sclerosis and stroke [40].
1.4.1.1 Endothelial cells
Endothelial cells line the inner surface of the blood vessel wall (Figure 1.8 on page 20). Tight
junctions, also known as zonula occludens, between endothelial cells were ﬁrst described in 1967
and are the most important factors for the BBB’s selective barrier function in mammals [41].
The tight junctions bind the endothelial cells closely together and are unique to the endothelial
cell type in the CNS [40]. They provide a potent barrier for virtually all microscopic organisms
and large, hydrophilic molecules, and also restrict ions and smaller molecules. The details of the
junction components have been the subject of great scientiﬁc interest. Our current understanding
of the molecular structure of tight junctions is largely based on studies in cultured endothelia
and epithelia and BBB endothelium [40].
Among the molecules known to contribute to the tight junctions are the transmembrane proteins
occludin and the claudins. Occludin is capable of linking zonula occludens protein 1 (ZO-1), and
its main function seems to be regulation of the tight junction [40].
Tight junctions signiﬁcantly restrict even the movement of small ions such as sodium and chloride
across the BBB, so that the transendothelial electrical resistance (TEER) can be increased 50-
fold compared to endothelium elsewhere in the body [42]. Claudins 3, 5 and possibly 12 appear
to contribute to the increased TEER [40].
In brain endothelial cells, the junctional adhesion molecules JAM-A, JAM-B and JAM-C are
maintaining tight junctions [43]. These transmembrane proteins are connected to the interior
of the cell by a complex mesh of proteins that form large protein complexes called cytoplasmic
plaques [43]. These plaques contain adaptor proteins with many protein-protein interaction do-
mains. This basically means that the proteins are able to interconnect at several sites, facilitating
formation of stable multi-protein structures. A recently-discovered protein, junction-associated
coiled-coil protein (JACOP) seems to be involved in connecting the junctional complex to the
actin cytoskeleton [43].
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The endothelial cells also have reduced vesicular transcellular transport compared to endothelium
elsewhere in the body, adding further to the barrier function [43].
1.4.1.2 Basal lamina
Separating brain capillaries, astrocytes, and pericytes is the basal lamina (Figure 1.8 on page 20).
The perivascular basal lamina is a very complex extracellular structure which originates partly
from astrocytes and partly from vascular cells. The basal lamina is a layer of extracellular matrix
proteins comprised of a number of collagens, laminin, ﬁbronectins, tenascin and proteoglycans,
this list not being exhaustive [44]. The basal lamina provides mechanical support for cell attach-
ment, serves as a substrate for cell migration, separates adjacent tissue, and acts as a barrier
to the passage of macromolecules. Cell adhesion to the basal lamina involves the integrins [45].
Integrins are transmembrane receptors that bridge the cytoskeleton of a cell to the extracellular
matrix.
1.4.1.3 Pericytes
In 1873 Charles Rouget described for the ﬁrst time a population of branched cells on the capillary
wall of the hyalloid of the frog and regarded them as contractile elements distinct from migratory
leukocytes [46]. Vimtrup, when studying capillaries in larvae tails, noted that contraction of
capillaries begins in these cells, calling them Rouget cells [47]. Zimmermann has been credited
to be the ﬁrst to use the term pericyte, originating from "peri" - around and "cyto" - cell
[48]. Pericytes are contractile cells surrounding the endothelial cell circumference with ﬁnger-
like projections, controlling the blood permeability of the capillary bed. They are polymorphic
cells with an oval cell body and long cytoplasmic projections oriented along the axis of the
blood vessels, perpendicularly branching oﬀ secondary and tertiary processes that grip the vessel
around its circumference [47]. Zimmermann described three subtypes of pericytes depending on
the adjacent vessel type, but suggested the existence of a continuum of a multitude of forms of
diﬀerentiation [49].
The study of pericytes presents some diﬃculties because pericytes are not easy to extract from
their location. There is also no pericyte-speciﬁc marker that enable us to perform certain single-
labelling immunohistochemical identiﬁcation. This problem is partly explained by the fact that
pericytes are multipotent cells, able to diﬀerentiate into diﬀerent subtypes and expressing various
amounts of potential pericyte-marker proteins. Double staining of contractile cell markers such as
the surface protein α-smooth muscle actin (α-SMA) in combination with an endothelial cell sur-
face marker is often used to separate pericytes and endothelial cells immunohistochemically [47].
However, α-SMA is also expressed by smooth muscle cells and not by all pericytes. Another
frequently used marker is the chondroitin sulfate proteoglycan NG2 which is also a neural pro-
genitor cell marker. Other surface markers in use are PDGF-β, VCAM-1 and ICAM-1, pericytic
aminopeptidase N, γ-glutamyl transpeptidase, and alkaline phosphatase, the xLacZ4 transgenic
reporter, and the regulator of G-protein signaling-5 (RGS-5) [47]. Many of these markers are
expressed in neighbouring cells, creating diﬃculties when trying to isolate the pericytes.
Pericytes are interspersed along the abluminal side of the endothelial cells in pre-capillary ar-
terioles, capillaries, and post-capillary venules, between the EC and the astrocytic endfoot [48].
They are covered by basal lamina on all sides (Figure 1.8 on page 20). Pericyte density along the
vessel tree varies between tissues. In the brain, pericyte-to-endothelia ratio has been estimated
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to 1:3, compared to 1:100 in striated muscle [50]. Other studies showed that pericyte coverage

















Figure 1.5: Simpliﬁed schematic illustrating pericyte functions. Pericyte with processes (red)
surrounds a capillary (blue). G. A. Gundersen.
Studies over the past twenty years have begun to disclose important roles of pericytes in regu-
lation of neurovascular functions needed for proper CNS homeostasis, including BBB formation,
vascular maintenance and architecture, as well as capillary caliber and blood ﬂow [53], regulation
of BBB function, neovascularization and angiogenesis, phagocytosis, and regulation of cerebral
blood ﬂow on the capillary level by contracting and thereby narrowing the capillary lumen (Fig-
ure 1.5) [47,48]. Pericytes are believed to play a role as the initiator of thrombin clot formation
in primary homeostasis, given its subendothelial localization [47]. Pericytes communicate with
endothelial cells through a series of signalling mechanisms, some of the most extensively studied
being the platelet derived growth factor-β (PDGF-β), transforming growth factor-β (TGF-β),
and Notch signalling, the latter being a group of four distinct heterodimeric receptors known
to be involved in embryonic vascular development. Notch-receptors initiate several steps lead-
ing to downstream transcriptional changes [53]. This cross-talk via signalling cascades enables
recruitment of CNS pericytes, maintains pericyte survival, and induces pericyte diﬀerentiation
and adhesion [53].
Considering the importance for BBB formation, recent studies in mice deﬁcient in PDGFr-β
demonstrated that BBB formation occurs early in embryogenesis, at approximately the same
time as pericyte recruitment and before generation of astrocytes [54]. In addition to pericytes
being necessary for development of BBB integrity, the authors found pericyte coverage of cap-
illaries to be important for tight junction development between ECs and for transendothelial
vesicle transport [54]. Abnormal pericyte function has been observed in CNS diseases such as dia-
betic retinopathy, neonatal intraventricular haemorrhage and in neurodegenerative processes [53].
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However, the detailed mechanisms underlying pericyte dysfunction in speciﬁc neurodegenerative
disorders such as Alzheimer’s disease is less understood.
Another recent study performed on pericyte-deﬁcient mice showed that pericyte-deﬁciency in-
creased permeability of the BBB to water and other diﬀerent-sized tracer molecules [55]. The
increased permeability was caused by increased transcytosis. The pericyte seemed to inﬂuence
the BBB in at least two ways. First, it altered endothelial gene expression. Second, it in-
duced polarization of astrocytic endfeet around CNS blood vessels [55]. Three markers for the
polarized astrocytic endfoot; the water channel AQP4, α-syntrophin and laminin-α2 chain, all
showed reduced vascular staining in absence of pericytes. In addition, AQP4 was redistributed
to other regions of the astrocyte [55]. This suggests that pericytes could be necessary for proper
localization of AQP4.
1.4.1.4 Astrocytes
In 1895 Lenhossek ﬁrst used the term "astrocyte" in his textbook on the CNS [56]. He presented
it as a replacement for the term "glial cells" in higher vertebrates as an eﬀort to get away from the
term "glia" (Greek, "glue"), indicating a passive function of this cell type [57]. The astrocyte is an
abundant cell type in the CNS, outnumbering neurons at least in higher species [58]. Some report
that neurons outnumber astrocytes by 3 to 1 in mouse and rat cerebral cortex, but in human
cerebral cortex, astrocytes outnumber neurons by 1.4 to 1 [59]. The density of astrocytes varies
by a factor of 1000, from low levels in the nucleus accumbens to very high in the subventricular
zone [57].
1.4.1.4.1 Astrocyte classiﬁcation and morphology
Astrocytes are star-shaped glial cells located in the CNS. Astrocytes, also known as astroglia,
are one of three types of macroglial cells, the others being oligodendrocytes and ependymoglial
cells. Classiﬁcation of astrocytes presents some challenges compared to other CNS cell types
such as neurons and microglia, in that it is a heterogeneous group of cells with no unique marker
or hallmark characteristic. Classiﬁcation of astrocytes can be based on morphology, lineage or
antigenic phenotype. In the beginning of the 19th century, astrocytes were subclassiﬁed into
protoplasmic and ﬁbrous astrocytes [57]. In time, more subtypes were discovered and given spe-
cial names, such as the Müller cell in the retina and the Bergmann glia in the cerebellum. In
2006, Emsley and Macklis deﬁned 9 classes of astrocytes based on three diﬀerent labelling meth-
ods - GFAP-GFP-expressing transgenic mice, and GFAP and S100β immunostaining, both glial
markers, although not present in all astrocytes [60]. The 9 subtypes suggested were tanycytes,
"radial" cells, Bergmann glia, protoplasmic astrocytes, ﬁbrous astrocytes, velate glia, marginal
glia, perivascular glia, and ependymal glia, and the authors clearly stated that several popula-
tions can exist within one brain area [60]. In general, primate astrocytes are found to be more
complex than rodent astrocytes, they are larger, have more processes, and one speciﬁc astrocyte
subtype, the interlaminal astrocyte with its long, corkscrewed processes, is unique to primates
and not found in the rodent brain [57]. This introduction will not go in detail on speciﬁc mor-
phological subtypes. The main subtypes investigated in the experimental body of this thesis are
the perivascular astrocytes in the cerebral cortex and the Müller cells of the retina.
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1.4.1.4.2 Astrocyte function
In contrast to neurons, astrocytes are not electrically excitable and do not ﬁre action potentials.
For many years, astrocytes were considered mere gap-ﬁllers in the brain, with no other functions
than their name glia (Greek, "glue") suggests. Today, astrocytes are known to have multiple
important functions and prominent roles in brain physiology. The subject of astrocyte function
is closely related to astrocyte heterogeneity, which will be discussed below. In the following a
selection of important astrocyte functions will be introduced, and more will be discussed in the


















Figure 1.6: Simpliﬁed schematic illustrating key astrocyte functions. Illustration shows astrocyte
(green) with an endfoot process covering pericyte (red) and capillary (blue). G. A. Gundersen.
Extracellular potassium regulation is one of the crucial functions of astrocytes. Astrocytes con-
tribute to maintaining an optimal and stable extracellular environment for neurons in general,
and their synaptic regions in particular. Extracellular potassium homeostasis is maintained
by diﬀerent mechanisms, such as spatial redistribution of K+ through gap-junction-coupled as-
trocytes ("spatial buﬀering"), active uptake by the Na+/K+-ATPase, and K+ uptake through
speciﬁc transporters and channels. By spatial buﬀering, K+ ions enter and leave the astro-
cytes at regions of high and low extracellular K+ values, respectively, with no net uptake [61].
Spatial buﬀering of K+, as ﬁrst described by Orkand in 1966, involves inﬂux and eﬄux of K+
through astrocytic K+-channels such as Kir4.1 [62]. The quantitative importance of this mode
of K+-removal is not known, and mathematical modelling indicates that the absolute amount
of K+ actually being cleared away by this mechanism is negligible [31]. The Na+/K+-ATPase
is an active transport mechanism, continuously transporting K+ into the cell in exchange for
Na+. Passive transport can occur through the Na+/K+/2Cl− cotransporter 1 (NKCC1) or by
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electroneutral KCl uptake through separate K+ and Cl− channels [61].
Glutamate uptake and subsequent conversion to glutamine is a well known function of astrocytes.
Glutamate is taken up from the perisynaptic ECS, converted to glutamine intracellularly and
released to the ECS as part of a process known as the glutamate-glutamine cycle [63]. Following
synaptic transmission, glutamate is taken up into the astrocytes via glutamate transporters
EAAT1 and EAAT2, moving against its concentration gradient by coupled transport to Na+ and
K+ [64]. Inside the cell, glutamate is converted by glutamine synthetase (GS) to glutamine and
transported out of the astrocyte and back into the ECS for uptake by neurons. In the neurons,
glutamine serves as a substrate for glutamate production and thus completing the cycle [63]. In
addition to replenishing stores of glutamate, this activity rapidly clears the perisynaptic ECS of
glutamate, preventing the neurotoxic eﬀects seen at high concentrations of glutamate. Astrocytes
also release neurotransmitters such as glutamate [65], and perform uptake of GABA [66] and
ATP [67], although the importance of the latter activity is unknown. Speciﬁc transporters for
other neurotransmitters such as GABA, glycine, adenosine, monoamines and serotonin has also
been characterized [64].
Sensation and modulation of synaptic activity by astrocytes has been an evolving ﬁeld in re-
cent decades. The close structural and physiological interactions with neurons suggests that
glial cells could be an active partner in synaptic transmission. The term "tripartite" synapse
was introduced to emphasize the point that the third element of the synapse, the glial cell, is
an essential component in determining synaptic function, along with the pre- and postsynaptic
neurons [68]. Not all synapses in the CNS are covered by astrocytes. In the hippocampus, it has
been reported that 57% of all synapses are associated with astrocytic processes [69], whereas in
visual cortex, one study reported 29% endfoot coverage of synapses [70]. The communication
between neurons and astrocytes at the synapse appears to be two-way. Neurons signal to astro-
cytes by release of neurotransmitters, while astrocytes signal in various ways, including release
of chemical transmitters [64]. Glial cells express many of the same transmitter receptors as neu-
rons, notably AMPA, NMDA, metabotropic glutamatergic receptors, GABAergic, adrenergic,
P2X and P2Y purinergic, serotonergic and muscarinic receptors, and a multitude of peptidergic
receptors [64, 71]. Astrocytes are interconnected by gap junctions, creating a network in which
they can communicate by intercellular pathways [72]. Following synaptic transmission, the sig-
nal from a "sensory" astrocyte can spread through this glial network by intracellular calcium
elevations [71]. Intracellular calcium elevations can propagate over long distances in the astro-
cytic syncytium and are thought to be important communication mechanisms [73]. Calcium
signalling will be further discussed below. Astrocytes have also been shown to modulate neu-
ronal activity directly, e.g. by relase of glutamate or ATP, by potentiating inhibitory synaptic
transmission [74] and by TNF-α-dependent control of the strength of excitatory synapses [75,76].
Astrocytes can also modulate synapses indirectly, notably by neurotransmitter uptake or glial
release of cofactors, such as the NMDA receptor modulator D-serine [77].
Astrocytes are involved in neuroenergetics. believed to provide neurons with lactate as an alter-
nate energy source to glucose [78]. A study ﬁrst determined the presence of lactate transporters
MCT1 and MCT2 in the adult mouse brain. The authors then showed how the lactate dehydro-
genases LDH1 and LDH5 are distributed among neurons and astrocytes in a fashion that suggests
a population of astrocytes as the lactate "source" while neurons being a lactate "sink" [78]. The
authors move on to provide biochemical evidence that lactate is interchangeable to glucose as a
substrate in oxidative metabolism in cortical neurons [78]. Recent studies have suggested a role
of astrocyte regulation in controlling neural tissue supply of energy sources through regulation
of blood ﬂow. This idea emerged after observations showing that astrocytes stimulated by glu-
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tamate released a group of vasodilator substances called epoxyeicosatrienoic adics (EETs) [79].
Later studies have provided data supporting this possible control of blood supply as yet another
function of astrocytes [80].
In case of neuronal death, due to for example ischemia after stroke, trauma or infection, the
astrocytes proliferate at the site of destruction to form a glial "scar" by a process known as
gliosis [81]. Astrocytes also secrete growth factors for neurons and axons and provide structural
support as part of the cytoarchitecture in the developing CNS [64].
1.4.1.4.3 Astrocyte heterogeneity
The fact that astrocytes are able to perform such diverse functions as outlined above suggests
that they are not all alike. Indeed, for over thirty years it has been known that astrocytes are
heterogeneous, meaning that astrocytes diﬀer across diﬀerent areas of the CNS according to
which particular functions they are supposed to perform [82]. As noted above, nine diﬀerent
morphological variants has been described [57], but heterogeneity is more than structural dif-
ferences. Astrocytes diﬀer in a multitude of functional properties, both across and within brain
regions [83]. Astrocyte heterogeneity has been observed in glial development, gene expression,
physiologic functions and in response to injury and disease [83]. The following paragraphs will
elaborate on astrocyte characteristics expressing heterogeneity. Some of the functions introduced
in the previous section will be reconsidered here from a perspective of heterogeneity.
Membrane conductance of astrocytes consists of passive currents, e.g. by uptake of potassium
from the perisynaptic ECS following synaptic activity and conductance of that electric unbal-
ance along the cell [57]. This membrane conductance is thought to be mediated by the most
abundant potassium channel of CNS astrocytes, Kir4.1, and the TREK potassium channels [84].
Kir4.1 expression levels vary across brain regions, being high in the ventral horn of the ventricles
compared to very low Kir4.1 levels in the apex of the dorsal horn [57]. Patch-clamp recordings
conﬁrmed signiﬁcantly smaller K+ uptake currents in the dorsal horn compared to the ventral
horn, suggesting that the uneven Kir4.1 expression levels have functional implications for K+
clearance rates in these regions [57]. The membrane conductance heterogeneity is observed not
only across brain regions, but across developmental stages within one region [84].
Heterogeneity of astrocyte expression has also been shown for other membrane proteins, such
as Ca2+-channels and glutamate receptors [57]. Glutamate receptors are considered a general
characteristic of astrocytes. In the rat supraoptic nuclei, one has observed a large population of
astrocytes that are morphologically similar to radial-type glia, but lacks glutamate receptors [85].
They do, however, express GABA-channels. Interestingly, an adjacent population of astrocytes
with round cell bodies and few processes proved to have functional glutamate receptors [85]. To
emphasize a general point, this heterogeneity of transmitter receptor expression in astrocytes
can be observed for receptors for GABA, glycine, beta-adrenergic agonists, and metabotropic
receptors for purinergic agents [57].
An important feature of astrocytes is reuptake of neurotransmitters following synaptic activity
in neurons. This clearance of transmitters from the ECS into the astrocyte is mediated by
transporters. Also neurotransmitter transporters are subject to regional heterogeneity. A study
of the astrocytic GLT-1, a glutamate transporter molecule for clearance of glutamate from the
ECS after synaptic release and for prevention of glutamate-related excitotoxicity. The authors
made transgenic mice with coexpression of DsRed under control of the GLAST promoter and
GFP under the control of the GLT-1 promoter. They found 10-fold higher GLT-1 levels in brain
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astrocytes compared to astrocytes in the spinal cord [86].
Astrocytes are connected to each other by gap junctions. Eﬀorts have been made to study the
amount of gap-junction connectivity between astrocytes in diﬀerent regions of the brain and at
diﬀerent developmental time points. Signiﬁcant diﬀerences have been observed [57]. Notably, in
grey matter the astrocytes form large networks, syncytia, with many interconnections for any
individual cell, whereas in white matter in the corpus callosum, coupling between astrocytes
are low and single astrocytes with no gap-junction connections can be observed [87]. Cortical
astrocytes form three-dimensional networks in general, whereas Bergmann-glia in the cerebellar
cortex are organized in a layer network [57]. When comparing mice of diﬀerent ages, more gap-
junction connectivity, assessed by biocytin-injections, has been observed in younger mice when
compared to older adults [88].
Astrocytes have two modes of calcium signaling; spontaneous calcium oscillations in individual
cells and a coordinated form as an intercellular calcium wave. Intercellular calcium waves propa-
gate in diﬀerent ways across diﬀerent populations of astrocytes. In the cortical three-dimensional
networks, the signal is generally transferred by the multitude of gap junctions, whereas in the
corpus callosum where gap-junction coupling is low or absent, the signal is conveyed by ATP-
release [89]. Studies on mouse brain slices and human astrocytes in culture showed that Ca2+-
waves travel faster in human cells [57], it is not known if this is due to morphological diﬀerences
between species.
Diﬀerences in volume-regulatory responses between populations of astrocytes have been observed
both after ischemic and hypo-osmotic stress in slices [57].
One interesting subtype of the astrocyte family is located in the retina of the eye. The retina is
a highly specialized extension of the CNS, of the same embryological origin. It contains similar
cell types as the neocortex of the brain, and its astrocyte subtype is called the Müller cell. The
Müller cell structure is tailor-made for ﬁtting the cell layers speciﬁc to retina, i. e. it favours
the uninterrupted travel of light acting as an optical ﬁber [90], but in essence it performs similar
main functions as the astrocytes found in the cortex of the brain [91].
Taken together, it is clear that astrocytes are a diverse group of cells exhibiting a wide range of
subspecialized functions and ample diﬀerentiation across many attributes.
1.4.1.4.4 Astrocyte polarity
The concept of functional and morphological subspecialization is well known on the level of
macroglial cell types as regional heterogeneity, as described above [91]. The same principle of
subspecialization is observed on the level of individual cells. Diﬀerent cell membrane domains
with diﬀerent functions contain diﬀerent molecules, e.g. receptors and transporter proteins.
This targeted expression of proteins to speciﬁc domains of the cell membrane is referred to as
polarization or polarity.
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Figure 1.7: Schematic illustrating glial cell polarity. The glial cell (green) has numerous processes
facing diﬀerent compartments in the cells microenvironment. In gliogenesis, radial glia, like
Müller cells, ﬁrst develop two "stem" processes facing a ventricle or the subretinal space (P0)
and a mesenchymal surface covering a ﬂuid compartment (P1) like pia, the vitreous body or
a blood vessel. Then additional processes develop, such as the perivascular endfeet facing the
vascular tree (P2), processes facing neurons (P3), their axons (P4) and dendrites. Not all glial
cells contain all process types. G. A. Gundersen.
Cell polarization in the CNS was ﬁrst described in 1865 by Deiters, who identiﬁed axons and
dendrites and assigned diﬀerent functions to them [91]. Polarization enables diﬀerent membrane
domains to perform diﬀerent functions. Astrocytes are traditionally regarded as polarized cells,
but this term indicates a "two-domainal" membrane distribution of molecules. Although this
might be descriptive for individual molecules, the astrocyte membrane as a whole is more com-
plex. Astrocytes have several diﬀerent well-deﬁned membrane domains, hence a multi-domainal
perspective might be more appropriate [91].
To understand glial cell polarity, it is useful to review the developmental stages. Mature as-
trocytes have a cell body with a nucleus and numerous cellular processes (Figure 1.7). These
long processes extend to important structures in the cell’s surroundings where the astrocytes
perform their functions. In the young developing CNS, the bipolar shape of radial glial cells is
predetermined by the two surfaces of the neural epithelium which the cells are in contact with
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by their two opposite stem processes. Some subgroups of radial astrocytes such as tanycytes
and Müller cells preserve this fundamental basal-apical polarity, although the mature cells also
develop additional processes to nearby structures [91]. As the CNS develops, the growing mi-
croenvironment of an astrocyte increases the number of possible contacts, and thus increases in
complexity from the embryological starting point of just two nearby epithelial surfaces. Given
this situation, it has been proposed that the deﬁnition of astrocyte cell polarity should not be
based on the two-sided embryological "stem"-process, but on the numerous "side"-processes that
emerges during development [91].
The distal end of an astrocytic process is called the astrocytic endfoot. The endfeet are in
contact with all structures surrounding astrocytes such as neurons, neuronal synapses, capillaries
and the pial surface, and in case of the Müller cell, the subretinal space [91]. Polarity has
been observed and partially characterized in processes facing microvilli, the outer retina, and
peripheral astrocytic processes [91]. However, in this thesis we will focus on the subgroup of
endfeet facing capillaries, namely the perivascular astrocytic endfeet. These specialized structures
exhibit strong polarization of membrane proteins and appear to be important entities at the BBB.
In this thesis we are particularly interested in these processes as they appear to serve important
functions for ﬂow of water, transport of electrolytes and as regulators of local cerebral blood
ﬂow. Notably, the water channel AQP4, the K+-channel Kir4.1 and anchoring proteins of the
dystrophin family are polarized to these astrocytic processes, while existing in relatively lower
levels in other astrocytic membrane domains. We will in the following sections focus on the
perivascular astrocytic endfoot and its membrane proteins.
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1.4.1.5 The perivascular astrocytic endfoot
The astrocytic endfeet cover more than 99% of the capillary endothelial cells along the capillary
[24]. The area of endothelial wall that supplies the brain is large; in each cubic centimeter of
brain there is about 100 cm2 of endothelial membrane [92]. Accordingly, the concentration of






Figure 1.8: EM-micrograph from the cerebral cortex shows the astrocytic endfoot (green) cov-
ering the endothelial cell (blue) and the pericyte (red), separated only by their basal laminas
(BL). Gold particles (arrows), 15nm in diameter, represent AQP4 water channels in the endfoot
membrane facing the capillary. G. A. Gundersen.
The perivascular endfoot is only separated by a distance of 35-40 nm from the endothelial cell
of the capillary wall by the basal lamina (Figure 1.8). Perivascular endfeet appear in several
stages of astrogliogenesis, ﬁrst by the development of the primary glial process abutting pre-
existing mesenchymal surfaces such as pia or a vessel wall [91]. Other perivascular processes
facing "younger" capillaries are developed "en passant" as the angioarchitecture matures and the
capillary system develops. The perivascular endfeet express high levels of speciﬁc transporter
proteins, ion-channels, and water channels, suggesting that this is an active zone of molecule
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exchange.
All the astrocytic and Müller cell processes facing a basal membrane share a typical structure
and similar anchoring protein complexes. They contain an unusually high amount of intramem-
branous orthogonal arrays of particles (OAPs), which main component is the water channel
AQP4 [91]. Studies of the endfoot membrane using immunogold labelling and mice knockout
models revealed that AQP4 is colocalized with the K+-channel Kir4.1 [93], and both channels
are associated with the dystrophin-associated protein complex (DAPC). Much is known about
the relationships and interdependency between AQP4 and members of the DAPC, this will be
discussed in more detail in later sections.
The endfoot membranes are practically covering all CNS capillaries and thus the majority of BBB
area, and therefore they are assumed to be important for both brain nutrient exchange and water
ﬂux [94]. They might also be involved in local regulation of cerebral blood ﬂow by crosstalk with
pericytes [4]. The perivascular endfeet can be important in at least two other functional aspects.
Uptake of glucose and lactate from peripheral blood is crucial for CNS energy metabolism. The
relative distribution of the CNS glucose transporter GluT1 or the lactate transporter MCT1 in
perivascular endfeet compared to other astrocyte cell domains is not known . Today, there is
no evidence of a endfoot restriction of MCT1, and GluT1 is observed in perisynaptic neuropil
processes [95, 96]. Having introduced the anatomical substrates of the BBB, we will no look at
ways to transport water across these layers.
1.4.2 Water transport across the BBB
As outlined above, water is constantly moving between the diﬀerent ﬂuid compartments (Fig-
ure 1.1 on page 3). Here we will take a closer look at water transport across the BBB. Water
crosses the layers of the BBB by several diﬀerent mechanisms.
Water can diﬀuse directly through the lipid bilayer membranes of the BBB cell layers. As
outlined above, it is generally accepted that water diﬀusion is driven by osmotic and hydrostatic
gradients and limited by the intrinsic water permeability of the membranes. This traditional
view is being challenged, as recent studies have shown that water can be transported against
its osmotic gradient by co-transport with other molecules (see below) [30]. The intrinsic water
permeability of CNS membranes that do not contain water channels is unknown. In general,
water permeability of biological membranes diﬀer, and some, like the apical membrane epithelial
cells of the thin ascending loop of Henle, are virtually impermeable [97].
Water can follow hydrostatic and osmotic gradients through bidirectional water channels across
the BBB. This is dependent on the presence of water channels in the membranes. AQP4 water
channels are concentrated in perivascular astrocytic endfeet [98], but also present in endothelial
cells [99]. However, endothelial cells in brain, in contrast to other organs, lack AQP1 [27].
It is important to note that not all the anatomical layers of the BBB contains AQP4 water
channels [27]; they are primarily localized in the astrocytic endfoot membranes facing blood
vessels.
Water can be co-transported along with other molecules such as electrolytes, amino acids, glu-
cose, or lactate through their designated transporter proteins. This transport of water occurs
through both uniports or cotransporters [100]. This is believed to be an important mode of
water transport, particularly in the non-endfoot region of the astrocyte, which faces neuropil
and synapses [30]. Although supposed to be less important in the AQP4-rich astrocytic endfeet
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abutting the BBB, these mechanisms merit a more thorough discussion, because it oﬀers us a
broader perspective on astrocyte water dynamics.
Compared to the perivascular endfoot membrane, AQP4 is relatively scarce in the perisynaptic
parts of the astrocyte membrane [98]. The latter contains transporter molecules which maintain
homeostasis in the synapse. During neuronal activity, the synaptic cleft is ﬂooded with trans-
mitters, potassium and other substances from the pre- and postsynaptic neurons. A priori, the
osmotic gradients created should favor water ﬂux into the synaptic cleft during neuronal activ-
ity. Surprisingly, a study performed three decades ago revealed that the ECS actually shrinks in
volume during neuronal activity [28]. The shrinking of ECS is a robust ﬁnding, estimates vary
from 4-30%, depending on the mode of stimulation, preparation type, and area under investiga-
tion [28,101–103].
For the ECS volume in the synaptic cleft to be reduced during neuronal activity, water has to
ﬂow out of the ECS. Hence, water must be transported against its osmotic gradient. This can
not be achieved by passive, bidirectional water channels. Speciﬁc transporter proteins moving
substances out of the synapse following neuronal activity carry a ﬁxed amount of water molecules
per transported molecule [30]. This way, water can move against its osmotic gradients.
Considering the astrocyte as a whole, several transporters have been shown to be capable of
this "uphill" water transport; the K+/Cl− cotransporter, KCC [104, 105], the Na+/K+/2Cl−
cotransporter, NKCC1 [106], the glucose cotransporter, SGLT1 [107–113], the glial glutamate
transporter, EAAT1 [114], the GABA transporter, GAT-1 [115], the monocarboxylate trans-
porter 1, MCT-1 [116–118] and the dicarboxylate transporter 1, NaDC-1 [119].
Focusing again on the BBB, the question presents itself: which proteins contribute signiﬁcantly
to the water permeability? A variety of water-transporting transport proteins are expressed in
one or both of the endothelial membranes and in the astrocytic endfoot. Notably, the glucose
transporter 1 (GLUT1), NKCC1 and MCT1 may be involved in water homeostasis [30,120]
Finally, water can follow macromolecules across the interior of cells via receptor-mediated tran-
scytosis, a phenomenon characterised by an invagination of the plasma membrane following
receptor stimulation on the cell surface [7]. This is the mode of transport for insulin. Another
mechanism is adsorptive transcytosis, in this case low-volume invaginations of the cell mem-
brane occur independent of receptor-stimulation, and water follows along with albumin and other
plasma proteins before subsequently being released on the contralateral side of the cell [7].
Moving from blood to brain, the last anatomical component for water to cross is the perivascular
astrocytic endfoot. In the endfoot, membrane transporter proteins like AQP4 are anchored to
the interior of the cell by anchoring molecules [121]. These are scaﬀolding proteins associated
with the plasma membrane and the cytoskeleton. They constitute a framework which holds
membrane transporters within their intended membrane domains and prevent them from moving
freely in the phospholipid membrane plane. This is thought to be an important mechanism for
maintaining cell polarization.
It should be emphasized that we do not know the relative contributions of the various water
transport mechanisms. To cross all layers of the BBB, any individual water molecule can utilize
all the above modes of transport.
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1.5 Anchoring of aquaporin-4
Polarized expression of transporter molecules in speciﬁc domains of the cell membrane is depen-
dent on two things. First, the transporter must get to the designated membrane domain. Second,
it must be prevented from leaving. Membrane proteins can by default move freely within the
plane of the lipid bilayer membrane. To stay in one place they need anchoring. Anchoring pro-



















Figure 1.9: Diagram of the dystrophin-associated protein complex (red) in the membrane of an
astrocytic endfoot. Note the relationship between the anchoring molecules dystrophin (DP71)
and α-syntrophin. AQP4 (blue) is linked to α-syntrophin at its PDZ-domain (red). AQP4 is
dependent on α-syntrophin for normal expression and localization. G. A. Gundersen.
Loss of glial polarization is a feature of a number of diseases, including temporal lobe epilepsy,
Alzheimer’s disease, stroke, trauma and glioblastoma [122–128]. Loss of polarity implies loss
of normal function. This section will introduce the anchoring proteins known to be associated
with AQP4: dystrophin and the dystrophin-associated protein complex (DAPC), in particular
α-syntrophin.
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1.5.1 Dystrophin and the DAPC
1.5.1.1 Description
Dystrophin is a key component of the DAPC (Figure 1.9 on the previous page), a multiprotein
complex located near the plasma membrane. The DAPC is known to be important for anchoring
membrane proteins in skeletal muscle and other tissues, e.g. in the brain. The individual proteins
in the DAPC are interdependent on proper polarization and localization. The dystrophin gene is
the largest gene known in man, making up 1,5% of the X-chromosome. The dystrophin protein
comes in a variety of isoforms that are expressed in various degrees in diﬀerent cells and tissues.
The dystrophin isoform expressed in astrocytes is DP71 [129].
1.5.1.2 Role in pathophysiology
Defects in the DAPC are associated with a group of diseases called muscular dystrophies. Loss
of dystrophin causes Duchenne muscular dystrophy, a severe X-linked disorder characterized
by muscle degeneration, cognitive deﬁcits [130] and an abnormal electroretinogram [131]. The
cognitive impairment seen in these patients are associated with mutations in the gene coding for
the brain isoform of dystrophin, DP71 [132]. Loss of dystrophin is correlated with an upregulation
of utrophin, a dystrophin-related peptide [133, 134]. This could be a compensation mechanism
to preserve dystrophin function.
A milder disease variant than Duchenne is Becker’s muscular dystrophy, in which dystrophin is
expressed, but in insuﬃcient amounts, producing milder symptoms.
1.5.2 α-Syntrophin
1.5.2.1 Description
The anchoring molecule α-syntrophin is localized in the plasma membrane of the astrocytic
endfoot. It is a member of the DAPC and one of ﬁve members of the syntrophin family. All
syntrophin isoforms express two PDZ domains and a unique C-terminal region which can bind
to diﬀerent proteins and subsequently generate functional protein complexes (Figure 1.9 on the
preceding page) [135, 136]. In general, it is important for correct localization of other proteins
within the cell membrane. Several studies have mapped out these relationships in more detail.
α-Syntrophin is required for proper polarized expression of AQP4 to the perivascular astrocytic
endfoot [137]. It is also necessary for proper localisation of the scaﬀolding proteins dystrophin,
γ2-syntrophin and α-dystrobrevin-2, being itself dependent on the latter for proper localization
[138,139].
1.5.2.2 Role in pathophysiology
Studies on α-syntrophin knockout mice have shown a loss of polarization of AQP4 in astrocytic
endfeet in brain. In endfeet facing the pial surface the reduction was 50%, and in endfeet
facing capillaries the reduction was 90% [99], suggesting diﬀerent anchoring mechanisms in these
two subtypes of endfeet. There is no speciﬁc pathological phenotype associated with loss of
α-syntrophin.
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Having introduced the main anchoring molecules of AQP4, we will now turn to the water channel
itself, exploring it in more detail.
1.6 Aquaporin-4
1.6.1 Description
AQP4 is one of thirteen known aquaporins and aquaglyceroporins (Table 1.2 on the next page)
[140]. AQPs are present in a variety of tissues and cell types. For many years it was assumed that
cell membranes were freely permeable to water. During the 1960s through the 1980s, following up
on biophysical studies of the water permeability of erythrocytes and kidney tubules, evidence of
diﬀerent permeabilites between cell types emerged. The diﬀerences were consistent with a pore-
like mechanism. The ﬁrst identiﬁcation of an aquaporin (AQP1) was reported in 1992 [141].
Subsequent research in the ﬁeld has ﬂourished. Propelled by the assumption that aquaporins
are key players in brain water transport, and thus a key player in serious brain conditions such
as brain edema, the idea of AQP4 as a therapeutic target emerged.
AQP4 is the predominant water channel in the brain and in the basolateral membrane of principal
collecting duct cells in the kidney. It is particularly abundant at brain-ﬂuid interfaces as the BBB
and the ependymal-CSF barrier.
1.6.1.1 Molecular and supramolecular structure
AQP4 exists in three functional isoforms, and studies in oocytes have shown that they have
diﬀerent unit water permeability [142]. M23 is the prevalent isoform in the mammalian brain
[143]. AQP4 is expressed in the plasma membrane of astrocytes, supportive cells in tissue
containing electrically excitable cells such as neurons, olfactory epithelial cells, sensory hair
cells of the inner ear, and bipolar cells in the retina. The ∼30kDA AQP monomer is made
of six membrane-spanning helical domains and two short helical domains. In the middle is a
narrow water pore of ∼25Å (1Å=0.1nm). Four monomers combine into tetramers in the cell
membrane. In the middle of the tetramer is a central pore. AQP4 tetramers further assemble
into supramolecular square arrays, also called orthogonal arrays of particles (OAPs) [140, 144].
Freeze-fracture analysis has estimated that square arrays, composed of AQP4, span as much
as 50% of the surface area of astrocytic endfeet [98, 145]. Given that astrocytic endfeet cover
more than 99% of the capillaries [24], it is fair to assume that AQP4 has a crucial role in brain
physiology.
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Protein name Aquaporin-4
Gene Aqp4
Gene location, human Chr 18: 22.69-22.7 Mb
Isomers M1, M23, Mz
Size 323 (M1), 301 (M23) and 364 (Mz) amino acids
Subunit Homotetramer
Tissue expression CNS, kidney, skeletal muscle
Subcellular location Membrane, multi-pass membrane protein
Function Water conduction through plasma membranes
Table 1.2: Aquaporin-4 (www.genecards.org)
AQP4 plays a prominent role in a variety of pathophysiological conditions, and this is where
the major breakthroughs in our understanding of the water channel have been made. However,
research on the physiology of AQP4 has made slower progress. Until now, investigators have
yet to establish a plausible main physiologic function of AQP4 in brain. In the following we
will look at what is known of AQP4’s role in physiology and then turn to roles of AQP4 in the
pathophysiology of diﬀerent conditions.
1.6.2 Physiologic function of AQP4 in brain
In cells expressing AQPs in the plasma membrane, the permeability of water increases 5-50
fold compared to cells lacking AQPs [146]. Aquaporin-4 (AQP4) is one of the most abundant
molecules in brain and is particularly prevalent in astrocytic membranes at the blood-brain and
brain-liquor interfaces. Only recently has evidence accumulated to suggest that AQP4 is involved
in such diverse functions as regulation of extracellular space volume, potassium buﬀering, cere-
brospinal ﬂuid circulation, waste clearance, neuroinﬂammation, osmosensation, cell migration,
and Ca2+ signaling. In the absence of a selective AQP4 inhibitor, our knowledge of AQP4 is
largely based on experiments on knockout mice.
In Aqp4 knockout mice there is evidence of reduced seizure threshold, prolonged seizure activity
[147] and impaired olfaction [148], hearing [149], and vision [150].
AQP4 could play a role in K+ clearance from the synaptic cleft following neuronal activity. K+
is cleared by glial cells by several mechanisms, the main transporter proteins being the NKCC1,
Kir4.1 and the Na+K+ ATPase [31]. It was previously hypothesized that AQP4 could facilitate
potassium-buﬀering during neuronal activity, given its co-localization with the potassium channel
Kir4.1 [93]. Neurons release K+ when generating an action potential. It has been suggested that
astrocytes remove K+ from the extracellular space and distribute it to distant sites through
"siphoning" mechanisms [93]. Water follows the osmotic gradient created by this clearance,
leading to a shrinkage of the extracellular space. This in turn maintains the gradient for K+
by maintaining a high extracellular concentration compared to the interior of the astrocyte.
Although data supporting this hypothesis exists, it remains controversial [147,151–156]
That AQPs could be involved in cell migration and motility was proposed after AQP1-null
mice showed impaired tumor angiogenesis [157]. Later it was shown that astrocytes in brain
expressing AQP4 had increased migration towards a chemotactic stimulus [158]. The mechanism
underlying this increased motility is unknown. One hypothesis is that an osmotic gradient is
created at the leading edge of a astrocytic process pulling water in from the extracellular space
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to the migrating leading edge. This, however, has yet to be proven, and other mechanisms have
been proposed.
Studies in oocytes expressing both AQP4 and the vasopressin receptor V1aR have shown that
vasopressin-induced activation of V1aR was followed by a substantial reduction in cell water per-
meability. This indicates that AQP4-mediated water permeability might be partly regulated by
vasopressin. The reduced permeability seemed to be eﬀected by V1aR-dependent internalization
of AQP4 [159].
AQP4 has been shown to regulate ECS volume during neuronal activity, presumably by facil-
itating water ﬂux in response to changes in extracellular concentrations of ions and transmit-
ters [160].
Despite its abundance at the BBB, it is generally believed that the most important physiologic
role of AQP4 is yet to be determined, and there is a need for new studies to pursue this.
1.6.3 Role in pathophysiology
1.6.3.1 AQP4 in brain edema
Brain edema is a feared complication of brain disease, seen in conditions like ischemic stroke,
brain tumor, bacterial meningitis, or head trauma. It is characterized by water accumulation
in the brain. Based data from the World Health Organization from 2004, stroke is currently
the second leading cause of death in the Western world, ranking after heart disease and before
cancer. The pathophysiology of stroke is complicated, but one of the lethal complications is
brain herniation due to brain edema and high ICP. Reducing the development of brain edema
would greatly reduce the mortality in ischemic stroke and improve the prognosis for patients
aﬄicted.
There are two main types of brain edema: cytotoxic and vasogenic. In cytotoxic brain edema
there is a leakage of intracellular osmolytes into the extracellular space. This can be due to excess
hypo-osmotic stress or ischemic stroke [161]. The osmotic gradient that develops pulls water
from the circulation into the brain. This in turn leads to high ICP and risk of brain herniation,
a potentially lethal condition. Mice lacking AQP4 show reduced mortality and reduced water
accumulation compared with wild-type mice in models of cytotoxic edema. The current concept is
that lack of AQP4 protects the brain by decreasing water permeability over the BBB [162].
In vasogenic edema water enters the brain due to a leakage in the BBB. The excess water exits
via the AQP4-rich astrocytic endfeet in the glia limitans towards the subarachnoid space and to a
lesser degree over the BBB in capillaries. Vasogenic edema is seen in obstructive hydrocephalus,
brain tumors, brain abscesses, or in experimental models of intraparenchymal water infusion. In
models of vasogenic edema, mice lacking AQP4 show worse outcomes and increased mortality
compared to wild-type mice. In contrast to the situation in cytotoxic edema, in vasogenic edema
the lack of AQP4 worsens the condition by decreasing the water permeability over the brain-ﬂuid
interfaces, functionally obstructing the outﬂow of surplus water [163,164].
Aqp4 knockouts seem to have the same eﬀect in the spinal cord as in the brain in cytotoxic [165]
and vasogenic [166] edema, respectively.
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1.6.3.2 AQP4 in neuroinﬂammatory disease
Astrocyte expression of AQP4 has been shown to be altered in inﬂammatory diseases of the
brain. Studies have shown increased AQP4 expression in human multiple sclerosis [167, 168],
whereas in neuromyelitis optica (NMO) it was reduced [168]. Another study showed that the po-
larized expression pattern was lost along with the organisation of AQP4 in OAPs in autoimmune
encephalomyelitis [169].
NMO is an autoimmune inﬂammatory disease in which antibodies are produced against AQP4
in the host cells [170]. NMO-like lesions have been reproduced by passive infusion of AQP4-
antibodies in animal studies [171]. The optic nerve and the spinal cord are most commonly
aﬀected. The lesions diﬀer from those seen in multiple sclerosis, as do prognosis and optimal
treatment. NMO can also aﬀect the brain. The main symptoms come from loss of function of the
spinal cord or the visual system. Patients have varying degrees of visual disturbances, blindness,
weakness or paralysis in the extremities, loss of sensation and/or bladder, and bowel dysfunction.
Main treatment is high-dose intravenous corticosteroids, and when resistant to medical therapy,
plasmapheresis.
1.6.3.3 Alzheimer’s disease and ﬂuid transport
Alzheimer’s disease is a serious neurodegenerative disease leading to gradual cognitive impairment
and dementia. Cause and progression of the disease are not well understood. Studies have shown
that neurodegenerative processes are associated with atrophy of astroglia, and at later stages
of disease, later stages, astrocytes become activated and contribute to the neuroinﬂammatory
component of neurodegeneration [172]. Alzheimer’s disease is associated with increased levels of
amyloid-β in the CNS. Amyloid-β is created by cleavage of the amyloid precursor protein (APP)
[173]. Amyloid-β exists in two forms, as a solute and as aggregates called neuroﬁbrillary tangles.
The ﬁbrils form plaques in the CNS parenchyma. There are several theories that try to explain
what the main pathological process in Alzheimer’s disease really is. The amyloid hypothesis
states that deposition of amyloid-β leads to the accumulation of neuroﬁbrillary tangles, neuronal
loss, and ultimately dementia [174].
Turnover of amyloid-β in the CNS is high, approximately 8% per hour [175]. Even modest
increases in production or decreases in clearance will lead to accumulation and deposition of
amyloid-β in the brain. Eﬀective clearance is dependent on adequate transport systems.
There are two main mechanisms for removal of amyloid-β from the brain: eﬄux of the soluble
form into the peripheral circulation and enzymatic cleavage of both the soluble and the ﬁbrillar
form [176]. The main known receptors for amyloid-β transport from brain to blood and vice
versa are the low-density lipoprotein receptor related protein-1 (LRP1) [177]. LRP1 facilitates
transport of amyloid-β across the BBB from brain to blood. In the blood plasma, a soluble
form of LRP1, sLRP1, acts as a "sink" and binds 70-90% of plasma amyloid-β peptides. In
Alzheimer’s disease patients the level of sLRP1 is reduced and the free fraction of amyloid-β in
plasma increased [177].
The treatment options for Alzheimer’s disease spans wide, from symptomatic treatment to molec-
ular transportation aids as described above. This is an attractive ﬁeld of research from both a
medical, pharmaceutical and public health perspective. Given that the amyloid hypothesis is
correct, there is much value to be gained in a thorough understanding of the clearance of amyloid-
β.
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Immunotherapy has been developed in which anti-amyloid-β is administrated. The antibodies
bind amyloid-β in blood plasma and brain and facilitates its transportation across the BBB and
away from the CNS, thus mimicking the action of sLRP1 [177].
Regardless of whether amyloid-β is cleared from the brain parenchyma as a solute bound to native
proteins, or bound to drugs, removal from the brain is ultimately dependent on ﬂuid transport.
Hence, if it is dependent on ﬂuid transport, it is dependent on water transport across brain
ﬂuid compartments. This opens up the possibility that AQP4 could be involved in clearance
of amyloid-β and thus of importance in Alzheimer’s disease. Interestingly, a study performed
on the tg-ArcSwe mouse model of Alzheimer’s disease shows that astrocytes lose their polarized
expression pattern of AQP4 [125]. In endfeet in close proximity of the perivascular plaques, the
AQP4 is redistributed both by a reducted expression in the perivascular endfeet and an increased
expression in the astrocytic processes in synaptic regions [125].
1.6.4 AQP4 as a potential target for therapy
We have seen how AQP4 plays a central part in worsening or improving the outcome of dis-
ease, depending on the pathophysiological mechanism in play. After observing these disease-
modulating eﬀects, the scientiﬁc community has become excited about whether drugs could be
produced to enhance the beneﬁcial eﬀects of AQP4 in disease [178, 179]. Perhaps the most ob-
vious scenario in which to apply a drug is to use an AQP4-inhibitor during the acute phase of
ischemic stroke, to limit development of brain edema. Importantly, if a safe AQP4 inhibitor is
to be developed, we need both a profound theoretical knowledge of the molecular mechanisms in
action, a drug design that yields eﬃcient drug distribution in the target tissue and a thorough
analysis of possible side-eﬀects.
It should be emphasized that this approach to treatment is based on manipulation of water
ﬂuxes, hence it will also be important to assess and quantify the water transporting capabilities
of other proteins to expand the range of potential therapeutic targets.
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1.7 Unresolved issues
Molecular organization in the astrocytic endfoot is a relatively young ﬁeld of study in neu-
roscience. There are high hopes that this line of research in the long term can lead to new
therapies for serious diseases.
Brain water transport is important in pathophysiology of disease, but the mechanisms are poorly
understood on the molecular level. In spite of years of intense eﬀort, a drug that inhibits AQP4
in vivo has still not been developed. Nevertheless, promising results have emerged and drugs
have been shown to inhibit AQP4 water transport in vitro [180]. In the meantime, there are a
myriad related problems remaining to be solved. A subject of ongoing debate is the physiological
function of AQP4. This key function is still not believed to be clear. What is the likely role
of a molecule this abundant, located in such a strategically important position in the neuron’s
supply chain of nutrients? One study supports the hypothesis that AQP4 is involved in gas
exchange via its central pore [181]. Data from our group supports the hypothesis that AQP4
balance electrolyte concentration changes by regulating the volume of perisynaptic extracellular
space [160].
At the molecular level there are important unanswered questions regarding AQP4. How is it
anchored? We do know that both dystrophin and α-syntrophin are involved [135, 182], but a
direct interaction between AQP4 and DAPC molecules has not yet been demonstrated. Thus, it
is likely that hitherto unknown anchoring molecules participate. One of these unknown anchoring
molecules could be the drug target or genetic target of choice in medical treatment of disease.
The astrocytic endfoot is certainly rich in AQP4, but could there also be subdomainal diﬀerences
in AQP4 abundance? These are intriguing questions to pursue.
On a macroscopic level is the question of how AQP4 aﬀects brain ﬂuid dynamics. It might
be that the true purpose of AQP4 water transport action is hidden from the observers when
studied up close on a molecular level. A broader "bird’s eye" view of the ﬂuid transport in the
CNS as a whole might be a more appropriate perspective. Water ﬂux is a major exit route for
substances in the brain. It would be interesting to address whether AQP4 is so important for
water transport that loss of it leads to accumulation of unwanted substances. And if this is the
case the next question would be whether the substances are accumulated in amounts necessary
for disease development, parallel to the build-up of amyloid-β in Alzheimer’s disease.
There are multiple interesting threads to follow. We embarked on the issues we found most
compelling and had the appropriate methods to explore.
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1.8 Aims of studies
The overriding aim of this work was to better understand water transport in the brain and,
in particular, the precise distribution and roles of AQP4. We wanted to study the subject of
anchoring mechanisms of AQP4, using our tools for precise identiﬁcation and localization of
membrane proteins on the subcellular level. This section will present the aims of our individual
studies by giving a short clarifying explanation and then the plain scientiﬁc hypotheses.
1.8.1 Paper I
1.8.1.1 Aims
AQP4 is unevenly distributed in the cell membrane of astrocytes, a group of supporting cells in
the brain. This is known as polarization. The aim of this study was to get a better understanding
of the mechanisms underlying this AQP4 polarization in brain and retina. We also wanted to
clarify the importance of speciﬁc anchoring molecules for correct AQP4 polarization in macroglial
membrane domains.
1.8.1.2 Hypotheses
H1: Dystrophin expression in perivascular endfeet is equal in brain and retina.
H2: α-Syntrophin expression in perivascular endfeet is equal in brain and retina.
H3: AQP4 polarization in brain and retina is equally dependent on dystrophin.
H4: AQP4 polarization in brain and retina is equally dependent on α-syntrophin.
1.8.2 Paper II
1.8.2.1 Aims
AQP4 polarization in the endfoot is defective in animals that lack pericytes. In paper I we showed
that AQP4 is enriched in perivascular astrocytic endfeet facing capillaries. However, we noticed
that AQP4 seemed to be even more clustered in membrane regions facing pericytes. Are pericytes
inﬂuencing the polarization of the endfoot? The aim of this study was to assess whether or not
the expression of AQP4 diﬀered between endfoot subdomains. We also wanted to test whether
the pericyte aﬀects polarization of AQP4 anchoring molecules, such as α-syntrophin.
1.8.2.2 Hypotheses
H1: AQP4 is equally distributed in the astrocytic endfoot membrane subdomains facing endothe-
lial cells and pericytes in WT mice.
H2: α-Syntrophin is equally distributed in the astrocytic endfoot membrane domains facing
endothelial cells and pericytes in WT mice.
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H3: α-Syntrophin expression in the astrocytic endfoot membrane is not diﬀerent in the WT and
Aqp4 knockout genotypes.
H4: If H3 are false, α-syntrophin expression is not diﬀerent in astrocytic endfoot subdomains
facing endothelial cells and pericytes in Aqp4 knockout mice.
1.8.3 Paper III
1.8.3.1 Aims
We wanted to characterize AQP4 expression at the BBB and to resolve whether glial endfeet
and their AQP4 water channels actually regulate water transport between blood and brain. By
trying to establish a new glial-conditional Aqp4-/- mouse line and use this and a global Aqp4-/-
mouse line we also aimed to resolve the controversy concerning whether AQP4 is expressed in
endothelial cells.
1.8.3.2 Hypotheses
H1: Part of the perivascular pool of AQP4 is located in endothelial cells.
H2: Deletion of perivascular pool of AQP4 has no eﬀect on water accumulation in brain during
hypo-osmotic stress.
H3: Deletion of perivascular pool of AQP4 has no eﬀect on brain reabsorption of water in the
early postnatal period.




This study was partly inspired by the results of paper III, in which we showed that water
accumulates in mice lacking AQP4. Given the unfortunate situation of excess interstitial water
seen in pathological conditions such as brain edema, the question arose, how does water and
other superﬂuous waste products leave brain tissue? Does AQP4 play a role in this?
1.8.4.2 Hypotheses
H1: CSF does not enter the brain from the ventricular compartment.
H2: CSF does not enter the brain from the subarachnoid compartment.
H3: CSF does not follow paravascular pathways along large arterioles to penetrate into deeper
into the brain parenchyma.
H4: CSF does not migrate from the paravascular space to the interstitial space of brain parenchyma.
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H5: Interstitial ﬂuid in brain parenchyma is not transported to the cortical surface via a par-
avascular pathway along venules and veins.
H6: Increasing parenchymal resistance to ﬂuid ﬂux by the global knockout of the Aqp4 gene does
not alter CSF ﬂux through the interstitium.
H7: If there is a transparenchymal CSF ﬂux, it does not aid in the clearance of ﬂuid and solutes
from the brain interstitium.




2. Materials and methods
This chapter will describe the methods used by the author when contributing to the studies
in the thesis. The other methods used in the studies is described in detail in the respective
papers.
2.1 Methods to study astrocytic endfoot proteins
We used two diﬀerent imaging modalities of immunocytochemistry. The immunoﬂuorescence
method and confocal microscopy are used to study protein distribution on a cellular and regional
level. Proteins can be localized to speciﬁc cell-types and within a limited area of interest, e.g. the
cerebral cortex. To study subcellular distribution we use preembedding immunohistochemistry
and postembedding immunogold cytochemistry combined with electron microscopy.
2.1.1 Immunoﬂuorescence microscopy
2.1.1.1 Description
Immunoﬂuorescence microscopy provides the ability to detect the location and relative abundance
on a cellular level of any protein for which you there is an antibody. While conventional light mi-
croscopy is useful for describing micro anatomical structures, immunoﬂuorescence can show the
distribution of speciﬁc proteins within those structures. We used indirect immunoﬂuorescence,
meaning that two antibodies are involved. A primary antibody is linked to the target-protein.
Subsequently, a secondary antibody covalently attached to a ﬂuorescent dye binds to the primary
antibody. Exposed to light, the ﬂuorescent dye emits light and is visualized and photographed
in the confocal microscope. We can study several proteins in the same experiment by using mul-
tiple diﬀerent primary and secondary antibodies. The immunoreactivity in immunoﬂuorescence
microscopy is superior to postembedding immunogold cytochemistry.
2.1.1.2 Limitations of immunoﬂuorescence microscopy
Antibodies are notoriously unspeciﬁc. Although they are designed to target speciﬁc epitopes in
the protein of interest, sometimes the ﬁxation process crosslinks proteins of interest to neigh-
boring molecules, creating false positive or false negative results due to unspeciﬁc binding. We
addressed this potential problem by including knockout-mice lacking the protein of interest as
negative controls in the experiments.
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A common problem with ﬂuorescence techniques is photobleaching, which is the photochemical
destruction of a ﬂuorophore. The light needed to stimulate the ﬂuorophore is also destructive
to it at high intensities or prolonged periods of illumination. The time available to study the
section is limited by this process. This issue is, however, not a major concern in our studies.
Most sections are thoroughly analyzed and photographed in less time than what is needed for
ﬂuorophore dysfunction.
2.1.2 Electron microscopy
The study of proteins on the subcellular level requires a method for visualization and imaging
that conventional microscopy or immunoﬂuorescence microscopy can not provide. Modern elec-
tron microscopy combined with high-resolution cameras and imaging software can provide this
resolution [183, 184]. The method can localize target-proteins down to an error margin of 17
nm [183]. Nevertheless, membrane proteins are to small to show directly, so for proper visual-
ization they must be linked to something big enough and with suﬃcient electron density to be
visible in the electron microscope.
2.1.2.1 Semi-quantitative postembedding immunogold cytochemistry
The principal experimental procedure used by the author in this work is postembedding immuno-
gold cytochemistry. Brain tissue is ﬁxated, embedded in resin polymers for structural integrity
and cut in thin slices appropriate for electron microscopy. A primary antibody is linked to the
target-protein. Subsequently, a secondary antibody connected to a gold particle binds to the
primary antibody. The gold particle is electron-dense and can easily be visualized in the electron
microscope and photographed. Every gold particle represents a molecule of the target protein.
Images are analyzed digitally followed by a statistical analysis to get a numerical value of the
density of target-protein in diﬀerent parts of the cell membrane. This section will cover the
details of the procedure, from tissue preparation to the ﬁnal analysis of data.
2.1.2.1.1 Tissue preparation
Animals were anesthetized by an intraperitoneal injection of a mixture of chloral hydrate, magne-
sium sulphate, and pentobarbital (142, 70, and 32 mg/kg, respectively). Absence of interdigital
reﬂexes was assured before commencing perfusion. Retinas and brains were ﬁxed by transcar-
diac perfusion of ﬁxative (∼10 ml/min) [185]. The ﬁrst 0.2% dextran (MW 70,000) in phosphate
buﬀer (15 sec) was used to ﬂush the blood out of the vasculature. The mice were then ﬁxed
with a so-called pH-shift protocol [186]. This is a method that enables relatively good mor-
phology without using glutaraldehyde, which is a major advantage as formaldehyde ﬁxation
preserves immunoreactivity to a much higher degree than glutaraldehyde [186]. It involves the
use bicarbonate-buﬀered 4% formaldehyde, pH 6.0, followed by 4% formaldehyde, pH 10.5 (0.2%
picric acid was added to both solutions). The low pH in the ﬁrst solution prevents polymeriza-
tion of the formaldehyde, and thus enables better penetration and distribution of the ﬁxative.
When the pH is increased by the second solution, the polymerization process starts and the tissue
ﬁxates quickly [186]. Neck stiﬀness was acquired within 90 sec after thoracotomy, indicative of
successful ﬁxation. If the morphology was unacceptable, the alternative to the pH-shift proto-
col was ﬁxation by 0.1% glutaraldehyde at pH 7.4. As outlined above, the trade oﬀ by using
glutaraldehyde is losing immunoreactivity.
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For immunogold cytochemistry, small blocks of the eyecup and the parietal cortex were subjected
to freeze substitution and inﬁltration in Lowicryl HM 20 resin (Polysciences Inc., Warrington,
PA, Cat 15924), before labeling with primary and secondary antibodies, as described previously
[184,187].
1. Small blocks of the eyecup and parietal cortex were cryoprotected by immersion in increas-
ing concentrations of glycerol in phosphate buﬀer: 10% (0.5 h), 20% (0.5 h), and 30%
(overnight, 4◦C).
2. They were then placed on a specimen pin and plunged into propane holding -170◦C, cooled
by liquid nitrogen in a cryoﬁxation unit.
3. The specimens were then transferred to 1.5% uranyl acetate dissolved in
anhydrous methanol (-90◦C) in a cryosubstitution unit (AFS; Reichert, Vienna, Austria).
After 30 h, the temperature was raised stepwise by 4◦C per hour to -45◦C.
4. The samples were then washed three times with anhydrous methanol.
5. Sections were inﬁltrated with Lowicryl HM 20 resin (Polysciences Inc.) at -45◦C by adding
the following solutions: (a) Lowicryl/methanol in 1:1 ratio for 2 h;
(b) Lowicryl/methanol in 2:1 ratio for 2 h; (c) Pure Lowicryl for 2 h; (d) Pure Lowicryl
overnight. The Lowicryl was then changed to freshly prepared resin and the capsules
(Reichert) with the specimens were moved to Lowicryl-ﬁlled gelatin capsules in the G-
chamber.
6. The capsules were then transferred to a container ﬁlled with ethanol, and then polymerized
with UV light. The process starts at -45◦C for 24 h, and then the temperature is increased
by 5◦C per hour to a ﬁnal temperature of 0◦C.
2.1.2.1.2 Incubation
Sections were cut with a ultramicrotome (Reichert). Semi-thin sections of 500 nm were cut with a
glass-knife for light microscopic morphologic analysis. This enables the investigator to recognize
the area of interest, e.g. the cerebral cortex. Ultrathin sections of 80-100 nm were then cut with
a diamond knife, mounted on nickel grids, and processed for immunogold cytochemistry [188].
The sections were incubated sequentially in the following solutions at room temperature:
Day 1:
1. 50 mM glycine in Tris buﬀer (5 mM) containing 0.1% Triton X-100 and 50 mM NaCl
(TBST) for 10 min: to bind free aldehyde groups from ﬁxation.
2. Blocking solution, e.g. 0.2% milk powder in TBST for 10 min: to prevent unspeciﬁc binding
of IgG.
3. Primary antibody (e.g. anti-AQP4, 1 μg/ml; anti-α-syntrophin, 12 μg/ml) diluted in the
solution used in the preceding step, to label the protein of interest. Incubated overnight.
Day 2:
4. Rinsing in TBST in following sequence: 3 short dips, 10 min of incubation, followed by 3
short dips and 10 min of incubation
5. Same solution as in step 2 for 10 min, to prevent unspeciﬁc binding of IgG.
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6. Gold-conjugated secondary antibody (AQP4, 15 nm particles; Syn259 (the primary anti-
body for α-syntrophin), 10 nm particles) diluted 1:20 in TBST containing milk powder
(0.2%) and polyethylene glycol (0.5 mg/ml) for 2 h to prevent unspeciﬁc binding and
clumping of gold particles.
7. Gentle rinsing in distilled water: 6 brief dips. The sections were then dried.
8. First contrasting step by immersion in 5% uranyl acetate in 40% ethanol for 90s and then
rinsing brieﬂy 3 times in distilled water and dried to visualize membranes.
9. Second contrasting step by immersion in lead nitrate for 90s then rinsing brieﬂy in distilled
water and dried to visualize cellular and tissue components.
2.1.2.1.3 Evaluation
The sections were then examined in a FEI Tecnai 12 transmission electron microscope (FEI
Company, Hillsboro, OR). Wild-type and AQP4 knockout tissue were included in all experi-
ments for positive and negative controls. In all projects, all tissue used for quantiﬁcation and
analysis originated from one experiment. The investigators were blind to section genotypes at
all times.
2.1.2.1.4 Quantiﬁcation
The number of animals included from each genotype diﬀered between studies. Images were taken
from each animal and analyzed. Digital images were acquired with commercially available im-
age analysis software (analySIS; Soft Imaging Systems GmbH, Münster, Germany). We used
a version of the program called IMGAP that is custom-made for acquisition of high-resolution
digital images [189] and to enable semiautomatic quantiﬁcation of immunogold-labeled mem-
branes [190,191].
To analyze density of gold particles along a membrane, images of membrane segments were
recorded at a nominal magniﬁcation of 34,000-46,000 in 1376 x 1032 (8-bit) images. All membrane
segments were collected from Müller cell endfeet in the outer plexiform layer of the retina or
astrocytic endfeet in the parietal cortex. Endfoot membranes facing pericytes were analyzed
separately, but were merged in the ﬁnal analysis, as there at the time was no apparent diﬀerence
in labeling intensity compared to endfeet facing endothelium.
Membrane segments of interest were drawn in the overlay and assigned a type label. Gold parti-
cles in close proximity (23 nm; maximal theoretical distance of antibody-gold particle-complexes)
of each membrane curve were detected semi-automatically, and the program calculated the dis-
tance between the centre of gravity of each particle and its membrane curve. This distance was
used to exclude non-membrane-associated particles in the subsequent calculations.
Density was measured in number of particles per unit length of membrane (linear density of
particles).
All images, with associated curves, particles, and measurements, were saved to allow later veri-
ﬁcation and correction. Before unblinding, data quality was assured by evaluating outliers, i.e.
extreme values in gold particle linear density. Further analyses were done in analySIS and SPSS
(SPSS Inc., Chicago, IL).
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For membrane types with low labeling density, short segments will frequently show zero or
very low particle density. To control for this phenomenon in the statistical analysis, the total
number of gold particles associated with all membrane domains of one type was divided by total
membrane length analyzed. We found that this did not alter the statistical analysis signiﬁcantly;
hence the original data was used.
2.1.2.1.5 Statistical model and analysis
The following is a detailed description of the mixed model statistical method used speciﬁcally
for the quantitative analysis of immunogold experiments. It is fairly complex due to variation on
several levels in the data hierarchy. Our data varies both between genotypes, between individuals
within genotypes and between blood vessels within an individual animal. Statistical expertise
associated with our group aided in the choice of statistical method after a thorough exploratory
data analysis. Other statistical methods are described in the respective papers.
We let Yijk be count measurements for section (animal) i, membrane (ROI) j and image k. The
sections were divided into groups of diﬀerent genotypes. The observed counts were modeled by
a Poisson mixed model
Yijk|ui, vij , wijk ∼ Poisson(λijk) (2.1)
log(λijk) = log(RSeLenijk) + μ+ βj + γjg(i) + ui + vij .
Here, gi is the genotype of section i and μ, βj and γjg are ﬁxed eﬀects, where μ is the intercept
(the expected value when genotype and membrane are equal to their reference values (depending
upon the analysis)). Furthermore, βj represents the diﬀerence between membranes, and γjg
represents the diﬀerence between genotypes for diﬀerent membranes. In a second analysis, we let
β represent diﬀerence between genotypes and γ the diﬀerence between membranes for diﬀerent
genotypes. The segment length RSeLenijk was included in the model (as an oﬀset) to take
into account that the expected count λijk is proportional to RSeLenijk. The random eﬀect
ui represents variation between sections, the term vij represents variation between membranes
(inside sections), while wijk represents the variations inside membranes. The terms ui, vij and
wijk have the following distributions
ui ∼ N (0, σ2u), vij ∼ N (0, σ2v), wijk ∼ N (0, σ2w,j)
We allowed the residual term σ2w,j to vary between membranes. The chosen model structure was
based on likelihood ratio tests.
The ﬁxed eﬀects and variances of the random eﬀects were estimated by the R function glmer in
the lme4 package.
2.1.2.2 Preembedding electron microscopy cytochemistry
This technique diﬀers from the above in that primary, secondary and enzyme-linked tertiary
antibodies are linked to the target proteins before embedding in resin. The enzyme, when
activated by a reagent, yields electron-dense products that can be visualized in the electron
microscope. After embedding there is no need for post-processing of tissue slices other than
contrasting before photographed in the electron microscopy. Images are analyzed digitally to
evaluate the presence of target-protein in diﬀerent tissue areas cellular compartments.
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2.1.2.3 Limitations of electron microscopy
The postembedding technique are subject to problems of antibody unspeciﬁcity, as described
in 2.1.1.2 on page 35. To control for this phenomenon, knockout-mice were included in the
experiments as negative controls.
An issue speciﬁc for the immunogold procedure is the fact that the gold particle is not in the
exact same position as the protein of interest. The theoretical distance from antigen to the gold
particle’s center of gravity in our experiments are maximally 23.5 nanometers. It is impossible to
determine the precise location of the target protein. We met this problem by using the smallest
gold particles possible and counted only gold particles within this theoretical maximum distance
from the cell membrane.
Antibodies are not able to penetrate the resin used to embed the tissue before cutting and
imaging. This means that there are a limited number of epitopes available for the primary
antibodies. This is part of the explanation why the immunoreactivity in this method appears
inferior to immunoﬂuorescence microscopy. In practice this means that some antibodies can
yield a strong signal in immunoﬂuorescence experiments yet still be useless for immunogold
experiments.
In the preembedding technique, the additional number of steps in the experimental protocol
introduces variability and lessens reproducibility. The method is qualitative, and measure of
antigen quantity in a speciﬁc tissue area beyond "present" or "non-present" are not satisfactorily
accurate.
2.2 Technical description of methods
Detailed descriptions of the other methods, necessary for reproducing our experiments, are to be
found in the papers I-IV.
2.3 Animal models
Transgenic animals played a key role in the projects of this thesis. The past decade’s commercial-
ization of production of transgenic mouse lines enabled us to investigate phenotypes and perform
proper validation of antibodies in ways considered impossible only ﬁfteen years ago. This has
substantially improved the quality of antibody-based scientiﬁc projects by introducing reliable
negative controls.
2.3.1 Mdx3cv
This mouse line has mutation leading to a severe deﬁciency in all dystrophin isoforms, in contrast
to the regular Mdx mouse lines that only lack in full-length dystrophin. It has been used
extensively in studies on Duchenne muscular dystrophy. The mutation is located to the 5’
end of the dystrophin gene [192]. However, it does not completely eliminate translation of the
gene transcript [193].
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The phenotype shows alterations of breeding performance and both motor and behavioural char-
acteristics. The Mdx3cv mice have more unsuccessful matings that other strains and slightly
lower breeding performance than regular Mdx mice [192]. Muscle pathology has developed by
4 weeks of age, and the skeletal and diaphragm muscle pathology is similar to that observed in
regular Mdx mice. The animals also develop mild cardiopathy [192]. A behavioural study con-
cluded that the mice have expressed enhanced anxiety-related behaviour and reduced locomotion
compared to control mice [194]. Learning deﬁcits in Mdx3cv was weaker or similar to regular Mdx
mice [194].
2.3.2 Constitutive α-syntrophin knockout
This mouse line does not express α-syntrophin. It is a useful model for assessing the rela-
tionship between this anchoring molecule and the membrane proteins potentially connected to
it [195]. It is particularly interesting to us because of α-syntrophin’s close association with
AQP4 [135].
The abnormal phenotype of this mouse line is more subtle than for the Mdx3cv. Gross anatomy
and behaviour are indistinguishable from litter controls. The BBB has not been shown to be
abnormal. The animals have a delayed brain water increase and edema development following
hypoosmotic stress [99], as well as increased severity of hypothermia-induced seizure severity and
delayed potassium-clearance [94]. In a study comparing eﬀect of osmotherapy with hypertonic
and isotonic iv infusion of saline following ischemic stroke, the added eﬀect on brain water
resorption of hypertonic saline was eliminated in the α-syntrophin knockout line [126].
2.3.3 Constitutive Aqp4 knockout
Aqp4-/- mice were generated by GenOway by cloning and sequencing of a targeted region of the
murine Aqp4 gene in a 129/Sv genetic background. The strategy was to design a targeted locus
allowing us to delete exons 1Ð3 to avoid any expression of putative splice variants. Hence, a ﬂip-
pase recognition target (FRT)-neomycin-FRT-LoxPÐvalidated cassette was inserted downstream
of exon 3, and a LoxP site was inserted upstream of exon 1. After homologous recombination
in ES cells, ES-cell injection into blastocytes, and generation of chimeras, heterozygous ﬂoxed
mice were obtained by breeding chimeras with C57BL/6J females. Heterozygous ﬂoxed mice
were bred with C57BL/6J Cre expressing mice to generate mice heterozygous for the KO allele,
Aqp4+/-. The Aqp4+/- mice were then backcrossed with C57BL/6J mice for ﬁve generations
before intercrossing to yield Aqp4-/- and Aqp4+/+ (WTs). In this mouse line the Aqp4 gene is
deleted in all cells and tissues, and hence the mouse is deﬁcient in AQP4 [196].
Aqp4-/- does not exhibit any abnormal growth, development, survival or neuromuscular function
if not stressed. They have prolonged stimulation-evoked seizure duration and slowed potassium
kinetics [147], while another study established altered gap-junction connectivity and postulated
that the Aqp4-/- had increased spatial buﬀering of potassium [197]. On that note, it was published
that no functional interaction exists between AQP4 and Kir4.1 in retinal Müller cells [153]. No
major structural abnormalities in the brain is observed [198], this was reported in a study by
Verkman et al. following a report stating that Aqp4-/- signiﬁcantly altered BBB integrity [199].
In a subset of 612 mouse, about 10% manifested progressive encephalomegaly originating in
triventricular hydrocephalus and elevated ICP [200]. Aqp4-/- mice have increased extracellular
space without tortuosity change [201], impairment of selected forms of spatial memory and
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neurotrophin-dependent synaptic plasticity [202], and reduced expression of α-syntrophin and
dystrophin in perivascular endfeet [203]. Another study published ﬁndings that imply a role for
AQP4 in synaptic plasticity and associative fear memory in the amygdala by regulating GLT-1
expression [204]. The same group found recently that Aqp4-/- mice exhibited impaired memory
consolidation in the Morris water maze and reduced theta-burst induced LTP [205].
Taken together, the majority of ﬁndings on BBB integrity suggests that the BBB is largely intact
without major disruption.
2.3.4 GLT1 -eGFP/NG2 -DsRed double-transgenic mouse line
This mouse line was developed for two-photon in vivo laser microscopy and immunoﬂuorescence
microscopy by crossing GLT1 -eGFP (developed by Rothstein) with NG2 -DsRed mice (developed
by Jackson). Two genetic sequences has been added. The eGFP expression is driven by the
GLT1 -promoter, so that green ﬂuorescence is seen in astrocytes [86]. The DsRed expression is
driven by the NG2 -promoter, hence red ﬂuorescence is seen in contractile cells such as pericytes
and smooth muscle cells in the vessel wall (details in paper IV). It is a reporter mouse line, no
abnormal phenotype have yet been reported.
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In this chapter we address our scientiﬁc hypotheses (see 1.8 on page 31) for the individual projects
and draw brief conclusions.
3.1 Paper I
Immunoﬂuorescence showed that perivascular expression of dystrophin and α-syntrophin was
weaker in retina than in three diﬀerent regions of brain (dentate gyrus, cortex, and cerebel-
lum). Immunogold cytochemistry revealed a strong α-syntrophin signal in perivascular endfeet
in cortex, whereas in retina the signal was absent.
In cortex, deletion of dystrophin and α-syntrophin markedly reduced perivascular AQP4 im-
munoﬂuorescence. Immunogold cytochemistry showed that deletion of dystrophin and α-syntrophin
reduced the AQP4 signal over perivascular astrocytic endfoot membranes in cortex by 65% and
88%, respectively.
In retina, the AQP4 immunoﬂuorescence did not diﬀer between genotypes. Immunogold cyto-
chemistry showed that the AQP4 signal in perivascular Müller cell membranes was 70% higher
than in cortical astrocytes. Deletion of dystrophin reduced the AQP4 signal over perivascular
Müller endfoot membranes in retina by 35%, whereas, in contrast to our ﬁndings in cortex,
deletion of α-syntrophin did not change the AQP4 signal.
We concluded that the macroglial expression of dystrophin and α-syntrophin diﬀered between
brain and retina, and that AQP4 seems to have diﬀerent anchoring mechanisms in these two
regions of the CNS.
3.2 Paper II
AQP4 immuﬂuorescence labeling of GLT1 -eGFP/NG2 -DsRed double-transgenic mice, which ex-
press ﬂuorescent reporters in astrocytes and pericytes, revealed distinct AQP4 signal in astrocytic
processes adjacent to pericytes.
Immunogold cytochemistry conﬁrmed AQP4’s polarized distribution, with AQP4-signaling gold
particles clustered over astrocytic endfoot membranes adjacent to pericytes. Quantitative anal-
ysis revealed that the density of gold particles was 40% higher over membrane domains abutting
pericytes than over those facing endothelial cells.
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We next investigated whether this abundance of AQP4 in speciﬁc endfoot membrane domains was
paralleled with increased expression of the AQP4 anchoring molecule α-syntrophin. α-Syntrophin
immunogold signal was also concentrated in membrane domains adjacent to pericytes.
Deletion of Aqp4 reduced perivascular α-syntrophin labeling overall, as reported previously.
The diﬀerentiated pattern of α-syntrophin signal within the endfoot membrane was preserved in
the Aqp4-/- mice. Thus, in Aqp4-/- mice the α-syntrophin immunogold signal was signiﬁcantly
higher over endfoot membrane domains next to pericytes than over those next to endothelial
cells.
Our data support the concept that pericytes are important for regulating polarization of AQP4.
3.3 Paper III
The strategy to use the GFAP promoter to drive recombination in glia resulted in a complete
loss of glial AQP4 in the mutants, as measured by immunoﬂuorescence, and quantitative im-
munoblotting. Glial-conditional Aqp4-/- mice displayed normal AQP4 expression in kidney and
muscle.
Quantitative immunogold cytochemistry of wild-type, glial-conditional Aqp4-/-, and global Aqp4-/-
mice revealed that endothelial membranes does not contain AQP4 labeling.
Having resolved the controversy regarding the endothelial expression of AQP4, we went on to
study whether the glial pool of AQP4 regulates blood-brain water uptake. We showed that under
systemic hypo-osmotic stress, glial-conditional deletion of the perivascular pool of AQP4 led to
signiﬁcantly less water accumulation in the brain.
We also found that baseline brain water content was elevated in glial-conditional and global
Aqp4-/- mice. This eﬀect was evident already at postnatal day 8, suggesting that AQP4 facilitates
water reabsorption in early postnatal life.
There was no diﬀerence in BBB permeability of large molecular-weight molecules based on be-
tween glial-conditional Aqp4-/- and control mice.
We concluded that the blood-brain barrier is more complex than anticipated and that the glial
covering of brain microvessels in certain circumstances acts as a functional barrier to water move-
ment. Moreover, our data do not support the hypothesis that AQP4 is expressed in endothelial
cells.
3.4 Paper IV
Infusion of ﬂuorescent tracers of diﬀerent sizes into the lateral ventricle and the cistern magna
and subsequent analysis of vibratome sections, showed that CSF enters the brain parenchyma
mainly from the subarachnoid space, and not from the ventricular compartments. By electron
microscopy we conﬁrmed tracer accumulation in the paravascular space.
Intracisternal injection of radioactive tracers conﬁrmed this CSF recirculation behaviour. Within
45 minutes of injection, 40% of radioactive mannitol was detectable in the brain. Larger-sized
radioactive dextran accumulated more slowly.
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Two-photon in vivo laser scanning microscopy showed that subarachnoid CSF ﬂows into the
brain parenchyma from the cortical surface through a paravascular space along the outside of
penetrating arteries and arterioles. Tracers of diﬀerent sizes was equally transported, indicating
that their transit from the surface to the deeper parts of the brain occurs via bulk ﬂow of
CSF.
To follow the tracers in deeper parts of the brain, we did ex vivo analysis of ﬁxed vibratome
sections. At early time points, tracers was observed migrating out of para-arterial space into
parenchyma. At later time points, tracer was observed alongside veins in a para-venous space.
Tracer injected directly into the interstitial space in brain parenchyma was cleared along para-
venous pathways, either posterior-medially toward the internal cerebral veins or posterior-lateral-
ventrally along the external capsule until its exit from the parenchyma along the caudal rhinal
veins. This suggests that both CSF and ISF moving through the brain parenchyma are cleared
along the same para-venous drainage pathways.
Loss of AQP4 had no eﬀect on para-arterial bulk ﬂow transport of CSF tracer from the surface
to deeper parts of the brain.
Ex vivo imaging showed that deletion of Aqp4 markedly reduced CSF tracer inﬂux from the
paravascular space into the brain parenchyma.
Measurements of radioactive tracers injected directly into the interstitial space showed that
deletion of Aqp4 markedly reduced clearance of tracers, thus demonstrating that astroglial
AQP4 supports the bulk ISF ﬂow that drives the clearance of interstitial solutes from the brain
parenchyma.
After intrastriatal injection of radioactive amyloid-β, the compound was rapidly cleared from
the brain. Deletion of Aqp4 reduced the rate of amyloid-β clearance by 55%.
Fluorescent amyloid-β moved rapidly along the vasculature when injected in the striatum, ac-
cumulating along the microvasculature and large-caliber internal cerebral and caudal rhinal
veins.
After intracisternal injection of radioactive amyloid-β, total brain radioactive amyloid-β levels
increased in a manner comparable to radioactive dextran, indicating that a portion of amyloid-β
within the CSF compartment recirculates. Deletion of Aqp4 signiﬁcantly reduced bulk inﬂux of
radioactive amyloid-β into brain parenchyma.
We concluded that there seems to be a previously unknown CSF circulation system involved in
clearance of water and solutes from the interstitial space of brain parenchyma. AQP4 seems to




In this chapter I will discuss the implications of our ﬁndings. First I will reﬂect on the new insights
on astrocyte polarity and AQP4 anchoring mechanisms in endfeet. Next, the role of endfeet in
controlling water exchange between blood and brain will be discussed. Then I will zoom out and
discuss the new circulation pathway that might serve as a lymphatic-like system in the brain.
Finally, I will deal with some translational aspects of our ﬁndings and look ahead.
4.1 Astrocyte polarity and AQP4 anchoring mechanisms
Our interest in this subject was kindled by the observation that endfoot polarity of AQP4 is
lost in a number of diseases. Deeper knowledge of the anchoring patterns underlying endfoot
polarity might be useful for understanding disease pathophysiology. This thesis has increased
our understanding of AQP4 anchoring mechanisms. We ﬁnd that anchoring mechanisms of
perivascular AQP4 vary across two regions of the CNS, that is, between the Müller cells in
the retina and astrocytes in the cerebral cortex. We provide evidence that dystrophin and α-
syntrophin are more important anchoring proteins for AQP4 in brain than in retina, but that the
polarity of endfeet, measured by AQP4 expression patterns, is comparable in the two regions.
A possible explanation for this is that diﬀerent DAPC-molecules or scaﬀolding molecules are
responsible for endfoot polarity in retina as compared to those in brain. The idea of diﬀerent
DAPC subsets is supported by our ﬁndings that the relative contributions of dystrophin and
α-syntrophin seem to diﬀer in brain and retina. However, compensatory mechanisms might
be in play to diﬀerent extents in the two regions. We speculate that loss of dystrophin might
be associated with compensatory upregulation of utrophin, a dystrophin homologue in cortex
[133,134], and less so in retina.
Our novel observations of regional diﬀerences in anchoring of AQP4 are in line with the concept
of macroglial heterogeneity, considering the astrocytes a cell type of great diversity, expressing
regional subspecialization both in terms of morphology and membrane protein composition in
astrocytic processes [83]. These ﬁndings add a new level of complexity to the understanding of
anchoring of AQP4.
It seems feasible that other proteins could display the same phenomenon as observed for AQP4,
that is, to express diﬀerent anchoring mechanisms across regions of the CNS. It might be fair
to assume that it applies to many other CNS membrane proteins. It is important that future
projects take this possibility into account when investigating anchoring molecules in the brain.




Roles of endfeet in controlling bidirectional water
transport between blood and brain: possible barrier function of endfeet
After clarifying the diﬀerent regional patterns of anchoring proteins and linking this to the
polarized expression of AQP4 in glial cells in paper (I), we wanted to look in more detail at the
expression pattern within the perivascular endfoot. In paper II we found variable expression of
AQP4 not only across brain regions, brain cell types, or cell membrane domains, but also across
subdomains within the specialized cell membrane domain of the perivascular astrocytic endfoot.
These ﬁndings challenge the concept of astrocyte polarization as a "two-domainal" distribution
of proteins, and thus supports the view of a "multi-domainal" specialization of the astrocyte
membrane [91].
We ﬁnd evidence supporting that pericytes regulate perivascular AQP4 expression. In essence,
what we ﬁnd is that the endfoot AQP4 expression is higher when abutting a pericyte. This
suggests that the pericytes and the astrocytes interact. This is interesting in many aspects. The
presence of a pericyte often increases the distance from capillary lumen to neurons. One of our
hypotheses is that the endfoot membrane increases its water permeability to compensate for the
increased distance to capillaries. If so, what are the mechanisms regulating this compensation?
We speculate that pericyte secretion of agrin, known to bind β-dystroglycan [206], a member of
the DAPC, might contribute to the enhanced polarization of AQP4 in the endfoot membrane
facing pericytes. Evidence of pericyte-astrocyte crosstalk and indirect evidence that this partially
regulates the BBB has been described earlier [4]. If pericytes aﬀect polarity in astrocytes, other
cell types adjacent to astrocytic endfeet, like pial cells, might have the same ability. These
are intriguing subjects for future projects. Our ﬁndings reinforce the concept of multidomainal
polarity, and suggest that the astrocytic endfoot membrane subdomain towards the pericyte is
indeed specialized.
4.2 Roles of endfeet in controlling bidirectional water
transport between blood and brain: possible barrier
function of endfeet
There has been uncertainty regarding the presence of AQP4 in cells adjacent to the astrocytic
endfoot, i. e. endothelial cells. Notably, Amiry-Moghaddam et al. reported immunogold electron
microscopy data indicating an endothelial pool of AQP4 [99]. By combining gene knockout
technology with Western blotting and quantitative immunogold electron microscopy, we were able
to show that the AQP4 pool in the neurovascular unit is located exclusively in astrocytic endfeet
and not in endothelial cells (paper III). Our assertion is that previous studies documenting an
endothelial pool of AQP4 by electron microscopy studies have in fact misinterpreted "spillover"
signal of gold particles from the astrocytic endfoot as endothelial AQP4. This is possible because
the antigen-antibody-gold particle complex can span the short distance between an astrocytic
endfoot membrane and the adjacent endothelial membrane. Thus, if not controlling for this
phenomenon, one can misinterpret a gold particle really originating from an endfoot as being of
endothelial origin.
Our ﬁnding that brain endothelial cells are devoid of AQP4 is important. It is clear that eﬀorts
towards pharmaceutical interventions on AQP4 must adjust to this ﬁnding. Potential brain
edema-reducing AQP4 inhibitors should be designed to permeate the endothelial cell layer to
reach the astrocytic pool of AQP4.
After having ruled out an endothelial pool of AQP4, we were left with the glial pool. This
enabled us to study whether endfoot AQP4 limits water ﬂux into and out of the brain. We
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found that glial-conditional Aqp4 knockout mice have reduced brain water uptake compared to
wild-type controls during hypoosmotic stress. This suggests that the astrocytic endfoot AQP4
is a rate-limiting step in water transport across the BBB. The insights gained from study of
glial-conditional Aqp4 knockouts diﬀer conceptually from the traditional view of the BBB, as
they confer barrier function on the astrocytic endfeet, and not only on the endothelial cell as
previously believed.
The discovery that glial-conditional Aqp4 knockout mice had higher brain water content than
wild-types, both postnatally and as adults, suggests that endfoot AQP4 is important for re-
sorption of interstitial ﬂuid both early in development and in adulthood. The diﬀerences in
postnatal brain water content between Aqp4 knockouts and controls coincided with the devel-
opmental stage in which AQP4 expression became detectable in the wild-types, supporting the
hypothesis that reduced brain water absorption is AQP4-dependent.
We wanted to follow up on this and study how AQP4 was involved in drainage of interstitial
ﬂuid from the CNS. Along which pathways are ISF cleared? After resolving that AQP4 is absent
in endothelial cells, it was appropriate to raise the question of whether water released from
endfeet is drained along blood vessels instead of inside them. Theoretically, such a pathway
could also facilitate inﬂux of water along blood vessels and through the glial endfeet to brain
parenchyma.
4.3 AQP4-dependent CSF circulation pathway and waste
clearance
The brain is the only organ in the body without a lymphatic system. In paper IV we identiﬁed a
new brain-wide circulation pathway for CSF in mice, addressing a long-standing question of how
excess interstitial ﬂuid is cleared from the brain. This pathway involves rapid para-arterial inﬂux
of subarachnoid CSF into the brain interstitium, followed by clearance of ISF along large-caliber
draining veins. The continuous movement of ﬂuid appears to be a main contributor to clearance
of interstitial solutes, exempliﬁed by our results on mannitol and amyloid-β. Given that this
pathway is dependent on transglial water ﬂux and that it seems to serve functions similar to the
lymphatic system elsewhere in the body, we suggest that this system be called the "glymphatic"
pathway.
As described in the introductory part of this thesis, it has long been known that CSF is cleared
from the cranial cavity both by entering venules in subarachnoid villi and by drainage to lym-
phatic vessels in the cribriform plate. This led to a hypothesis stating that CSF might serve
"lymphatic" functions by exchanging solutes and ﬂuid with the brain ISF along the perivascular
space, and that the clearance route was largely para-arterial. This hypothesis was supported
by previous studies observing tracer accumulating around arteries after injections into the inter-
stitium [207, 208]. After obtaining results favouring a para-venous clearance route rather than
a para-arterial, our belief is that these observations of high para-arterial tracer concentrations
might be artifacts due to high intraparenchymal pressure after injection. Supporting this, when
injecting tracer intraparenchymally in our own experiments, we observed para-arterial accumu-
lation close to the injection site, but in areas at the furthest distance from the injection site, the
accumulation was largely para-venous.
By following diﬀerent-sized tracers, we were able to track the direction of CSF ﬂow. Both
TR-d3 and FITC-d2000 molecular tracers injected intracisternally moved along para-arterial
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pathways along pial surface arteries and into the Virchow-Robin spaces (VRS) of penetrating
arteries without mixing with the subarachnoid CSF compartment. This suggests that the para-
arterial space of surface arteries and the VRS is an anatomically distinct subcompartment of
the subarachnoid space. This propulsion of CSF along arteries are believed to be driven by
arterial pulsations [209, 210]. Small-size tracers followed the CSF ﬂuid from para-arterial space
into brain parenchyma, whereas large molecular-weight tracers were restricted. Previous studies
have addressed paravascular ﬂow and the distribution of tracers in the perivascular space [211–
214]. Our belief is that these studies have underestimated the magnitude of paravascular ﬂow.
Methodological diﬀerences may be the cause of these discrepancies. In our experiments, we
noticed that loss of hydraulic integrity of dural and subarachnoid space signiﬁcantly reduced the
paravascular ﬂow. This disruption could be caused e.g. by establishing external openings for
taking samples of ﬂuid, as has been done in some of the previous studies [211, 212]. Another
explanation for discrepancy could be the use of diﬀerent-sized tracers. Whatever the underlying
cause, our recent ﬁndings refute previous conclusions that para-vascular ﬂuid ﬂuxes are "slow
and variable in direction" [211,212].
Perivascular endfeet cover brain microvasculature almost completely, with only 20 nm clefts
between adjacent overlapping endfeet providing direct communication with the ISF [24]. Our
observations indicate that perivascular AQP4 facilitates the inﬂux of subarachnoid CSF from
para-arterial spaces into the brain interstitium, as well as the subsequent clearance of ISF via
convective bulk ﬂow. By characterizing this "glymphatic" pathway in both normal and AQP4-
deﬁcient mice, we show that it is largely dependent on AQP4, and that the recirculation of CSF
via para-arterial space is of considerable volume. Our observations suggest that in normal mice,
>40% of CSF recirculated through brain parenchyma in 45 minutes. Loss of AQP4 reduced
estimated recirculation by 70%. We speculate that arterial pulsations are the main driving force
of ﬂuid from para-arterial space and VRS through speciﬁc transporters in the glial sheet and/or
between glial processes. Our ﬁndings indicate that AQP4 is one of the transport molecules in
question. Out of all the diﬀerent water transport mechanisms across the BBB, our ﬁndings
might outline the relative contribution of the AQP4-mediated water ﬂux. We consider 70% a
substantial reduction, but notably about 30% of the recirculation volume remains in circulation.
This circulaton of water not being eliminated by knockout of Aqp4 must be accounted for by other
mechanisms and might be a rough quantitative estimation of the combined relative contributions
of co-transport of water through transporters and diﬀusion [30]. In light of our knowledge of
disrupted astrocyte AQP4 polarization in speciﬁc conditions like experimental stroke models,
Alzheimer’s disease and epilepsy, it would be of interest to address whether the "glymphatic"
pathways is aﬀected in these conditions. Another approach to explore the eﬀect of astrocyte
polarity disruption on the "glymphatic" system would be to do paravascular ﬂow experiments
on α-syntrophin knockout mice and glial-conditional Aqp4 knockouts.
After ﬂuid from the CSF has entered the ECS and mixed with the ISF, it is cleared together with
associated solutes along paravenous pathways. We speculate that the these paravenous spaces
and the dural sinuses provide a lowpressure sink that, in combination with arterial pulsations
within the subarachnoid space, create an arteriovenous hydrostatic gradient that drives paravas-
cular CSF bulk ﬂow and ISF clearance. When ISF reaches the parenchymal border and the
sheet of glial endfeet covering the paravenous space, water and solutes may cross this barrier by
diﬀerent modes of transport. In the case of amyloid-β, diﬀerent speciﬁc transporters have been
identiﬁed, notably the sLRP1, whereas for water the presence of AQP4 might provide a low-
resistance barrier for entering paravenous space. We do ﬁnd that amyloid-β is cleared from brain
interstitial more rapidly than comparable sized dextran, suggesting that solute-speciﬁc receptor-
mediated transport can increase the clearance rate. The hypothesis that AQP4 is rate-limiting
50
Chapter 4. Discussion Translational aspects
for eﬄux of water from the interstitium is supported by observations of enlarged ECS in Aqp4
knockouts [215]. This might be a compensatory mechanism to counteract higher para-venous
water eﬄux resistance in these mice. The "glymphatic" pathway does not necessarily provide
terminal clearance of ﬂuid from the paravenous space and out of the cranium. Previous studies
has suggested two routes for this clearance. First, the paravenous spaces enables the cleared
solutes to interact with BBB transporters and uptake. Second, for solutes not recycled over the
BBB, ﬂuid and solutes drained along caudal rhinal and internal cerebral veins could be cleared
to the systemic circulation through arachnoid granulations [216–218].
The "glymphatic" pathway seems to transport not only water, but also small to moderate-sized
molecules like amyloid-β, a key factor in the development of Alzheimer’s disease. Previous studies
have reported that intraparenchymally injected amyloid-β is cleared along paravascular pathways
[219]. We report that amyloid-β is cleared along the same paravascular pathway as other solutes
and that this pathway is signiﬁcantly compromised in Aqp4 knockouts. This is intriguing, because
reactive gliosis is one of the pathophysiological changes observed in Alzheimer’s disease and the
ageing brain [220–222]. We speculate that the altered AQP4 polarization and expression observed
in neuropathological conditions may reduce ISF bulk ﬂow and eﬄux and thus the clearance of
solutes contributing to the pathophysiological processes, such as amyloid-β [223]. On a slightly
diﬀerent note, our observations on amyloid-β-clearance support the previously proposed link
between AQP4 and Alzheimer’s disease [125], but from a slightly diﬀerent angle. In the cited
study, the Alzheimer’s disease mouse model showed alterations in AQP4 polarization following
plaque formation. In our present study the sequence of events are reversed, in that the initial
deﬁciency of AQP4 leads to a slowed clearance of amyloid-β, the protein known to form plaques
in Alzheimer’s disease patients. Although the distinction between redistribution of AQP4 and
plain loss of AQP4 is important, the main eﬀect of total loss of AQP4 is a reduction of the
perivascular endfoot pool, and thus the end result is not unlike loss of AQP4 polarization.
In contrast to diﬀusion, bulk ﬂow transport of molecules is independent of molecule size [224,225].
Based on this, Cserr et al. postulated that the bigger the brain, the longer would be the diﬀusion
distances needed to clear a solute from a given location in the interstitium, and thus the relative
importance of bulk ﬂow would increase as brain size increases [20]. This concept might be
important to keep in mind when extrapolating our insights from study of the rodent brain to
the human scale. In other words, the relative importance of the "glymphatic" pathway and ECS
bulk ﬂow of ISF could be more pronounced in humans than in mice.
This new circulation pathway could be a major breakthrough in the search for AQP4’s main
function. That being said, it reinforces one of the most puzzling traits of the AQP4-deﬁcient
mice: AQP4-deﬁcient mice does not have a lethal or even moderately disabling phenotype. This
holds true both for the global and the glial-conditional Aqp4 knockouts. This is plainly surprising
given AQP4’s abundance and importance for ﬂuid transport, and even more so in the face of this
new circulation pathway. What are the evolutionary selection criteria that favor the abundant
expression of AQP4 on brain ﬂuid compartment interfaces?
4.4 Translational aspects
The discovery of the "glymphatic" pathway opens up for intriguing new therapeutic possibilities.
By improving the AQP4-dependent bulk ﬂow one could speed up clearance of neurotoxic or neu-
rodegenerative agents, such as amyloid-β. One could also imagine increased "glymphatic" ﬂow
rate to increase immunosurveillance of the CNS, enabling faster immune responses when detect-
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ing foreign antigens originating in brain parenchyma without compromising immune privilege.
Immune cells like lymphocytes and antigen-presenting cells reside in the subarachnoid space, and
previous studies have indeed showed a reduced immune response in Aqp4 knockouts following
intraparenchymal LPS (a foreign antigen) injections [226]. On the other hand, slowing the "glym-
phatic" pathway could increase tissue concentration and exposure time in CNS parenchyma for
therapeutic agents such as anti-tumor drugs, immune modulators, and antibiotic agents.
Several groups, independently of each other, are trying to develop AQP4 inhibitors. This could
prove of therapeutic signiﬁcance in the long term, but in the meantime could prove important
for revealing functional aspects of AQP4. The inhibitor-enabled study of AQP4 functions will
be important for reducing patient risk before potential drug trials in humans can be considered
[227].
4.5 Future perspectives
The present work made an eﬀort to increase understanding of the localization and functions of
AQP4. We studied ﬂuid transport in the CNS on diﬀerent levels, spanning from the global CSF
circulation patterns to the molecular level of water channels in the membrane of individual cells.
This is basic science, but our hope is that these insights from animal experiments will contribute
the common scientiﬁc eﬀort towards new treatment regimes that will beneﬁt patients. We are
now initiating several follow-up studies.
We wonder if astrocyte heterogeneity can be important for clearance of ISF. If water permeability
of the perivascular glial "cuﬀ" varies along the vessel tree, such diﬀerences could direct ISF ﬂow
by creating low-resistance exit routes in areas of high-permeability.
We have already initiated an immunogold project that will resolve whether endfoot AQP4 expres-
sion varies along the vasculature. Today there are no generally accepted exclusion or inclusion
criteria to reliably diﬀerentiate arteries and veins in electron microscopy sections. We intend to
work around this problem by identifying the vessel type using two-photon imaging before prepar-
ing tissue for electron microscopy. Arteries and veins can be identiﬁed in the two-photon setup
based on blood ﬂow characteristics, vessel morphology, and presence of contractile cells express-
ing ﬂuorescent markers. Subsequently, we can dissect out the brain area and cut tissue sections
for microscopy. Vessels observed in the sections can then be compared to a 3D-reconstruction of
the two-photon recordings and identiﬁed as either artery or vein.
Our in vivo experiments were performed on wild-type and global Aqp4 knockout mice. The
growing body of evidence of Aqp4 knockouts having abnormal expression of diﬀerent proteins
must be considered when interpreting data. The sum of the many compensatory mechanisms
in play working to counteract the loss of AQP4 creates confounding eﬀects, setting investigators
up for misinterpretation of data. In upcoming projects, we intend to study the CSF circulation
patterns in several other mouse lines. By developing and characterizing the glial-conditional
Aqp4 knockout mice we have introduced a new tool and thus set the stage for interesting follow-
up studies. Glial-conditional Aqp4 knockouts, α-syntrophin knockouts and mdx3cv mice are
genotypes of interest in our upcoming projects. It must be emphasized, however, that the glial-
conditional Aqp4 knockout model are not strictly astrocyte-speciﬁc, but it can be considered
organ-speciﬁc, in that the only GFAP-expressing cells that also express AQP4 is located in
the CNS. This could prove useful in exposing animals for systemic stressors like hypoosmostic
infusions or hypoxic conditions, by eliminating the possibly confounding eﬀects of extra-cerebral
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AQP4, such as in kidney and lung tissue. In future research on AQP4 one can reﬁne the design of
the experimental setups by using glial-conditional Aqp4 knockout models and remain conﬁdent
that AQP4 is absent in the neurovascular unit. This targeted elimination of AQP4 and its
anchoring molecules in diﬀerent cell lines could enable us elaborate on the individual contributions
of each protein to the CSF circulation and ISF clearance. To follow up on the role of AQP4 in
clearance of amyloid-β, it would be interesting to study expression of AQP4 in tissue obtained
from the autopsy of Alzheimer’s disease patients.
Our ultimate long term objective is to deepen our understanding of brain ﬂuid dynamics to enable
development of better treatment for CNS diseases in humans and increase patient survival and
quality of life. Our studies are performed in mice and can never be more than a proxy for the
human brain.
A general limitation inherent in our experimental setups is the need to partly compromise bi-
ological, in vivo conditions to enable standardization of experiments and optimal control over
confounders. To illustrate a general point, injection of amyloid-β directly into mouse brain
parenchyma is no perfect simulation of the amyloid plaques in the human adult brain accumu-
lating over years and decades. This inevitable discrepancy between "real" and "experimental"
conditions is important and requires that we be careful when developing our conclusions so as
not to make claims not supported by data. A more speciﬁc description of the limitations of our
methods are found under materials and methods in Chapter 2 and in the respective papers.
The present work was performed on tissue slices, sections, homogenates and in living mice.
The author has mostly done electron microscopy, to this date the only way of obtaining high-
magniﬁcation, high-resolution images of structures on the subcellular level. Experimental setups
for in vivo imaging have now fully entered the ﬁeld of basal neuroscience and are already exceeding
the limits for what was previously thought possible. PET scanners, fMRI, CT, and multi-
photon laser scanning microscopy make real-time in vivo non-invasive imaging a reality, and the
resolution these techniques provide is continuously improving. There are high hopes that future
breakthroughs in the study of the gliovascular unit will come when combining scientiﬁc curiosity






Molecular scaﬀolds underpinning macroglial polarization: an analysis of retinal Müller cells and
brain astrocytes in mouse.
My contribution to this project was to quantify the amount of AQP4 and α-syntrophin in the
end-feet of astrocytes in the diﬀerent genotypes using semiquantitative post embedding immuno-
cytochemistry. I did image acquisition, statistical analysis, designed ﬁgures and contributed to
writing and proof-reading the manuscript.
Paper II
Evidence that pericytes regulate aquaporin-4 polarization in mouse cortical astrocytes.
My contribution to this project was to quantify the amount of AQP4 and α-syntrophin in the
end-feet of astrocytes in the diﬀerent genotypes using semiquantitative post embedding immuno-
cytochemistry. I did image acquisition, performed statistical analysis, designed ﬁgures and had
the main responsibility for writing and proof-reading the manuscript.
Paper III
Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers
barrier function on perivascular astrocyte endfeet.
My contribution to this project was to quantify the amount of AQP4 in the end-feet of astrocytes
in the diﬀerent genotypes using semiquantitative post embedding immunogold cytochemistry. I
did image acquisition, statistical analysis, designed ﬁgures and proof-read the manuscript.
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Paper IV
A paravascular pathway facilitates CSF ﬂow through the brain parenchyma and the clearance of
interstitial solutes, including amyloid β.
My contribution to this project was to identify VRS on electron microscopy in the diﬀerent
genotypes and qualitatively determine distribution patterns of diﬀerent sized tracers using DAB
immunohistochemistry. I performed experiments, image acquisition and analysis, designed ﬁg-
ures and proof-read the manuscript.
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Aquaporin-4 (AQP4) water channels are concentrated in astrocytic endfoot 
membranes at the brain-blood and brain-cerebrospinal fluid interfaces. The 
mechanisms underpinning the polarized distribution of AQP4 are poorly understood. 
Here we tested the hypothesis that pericytes regulate AQP4 anchoring to perivascular 
membranes. Quantitative immunogold analysis revealed that AQP4 expression was 
higher in endfoot membranes abutting pericytes than in those facing endothelial cells. 
Similar findings were made for α-syntrophin, a member of the dystrophin associated 
protein complex (DAPC). The enrichment of α-syntrophin in membranes ensheathing 
pericytes persisted after Aqp4 deletion. Our data support the concept that pericytes 










AQP4 regulates water transport across the blood-brain barrier (BBB) and along 
paravascular pathways.1, 2 Early immunogold studies revealed that AQP4 has a 
polarized distribution, with tenfold higher density in glial endfoot membranes than in 
other membrane domains.3 Later it was shown that the DAPC is essential for AQP4 
polarization in glia. Notably, mice deficient in dystrophin,4, 5 α-syntrophin,6, 7 
dystroglycan,8 or α-dystrobrevin9 show reduced perivascular AQP4 expression. The 
DAPC is attached to the perivascular basal lamina through binding between the α-
subunit of dystroglycan and the extracellular matrix components laminin and agrin.10 
Hence, loss of agrin reduces AQP4 expression in glial endfeet surrounding blood 
vessels.11  
The concept that vascular cells regulate AQP4 anchoring was bolstered by the 
discovery that pericyte-deficient mice showed abnormal AQP4 expression around 
blood vessels.12 However, the mutant mice used in this study had abnormal vessel 
diameter, disrupted BBB, and increased brain water content, which could have 
indirect effects on the subcellular AQP4 distribution. In the present study we used 
mice with intact BBB and investigated whether AQP4 anchoring in astrocytic endfeet 
depends on their intimate relationship to pericytes.   
 
 
Materials and Methods 
 
Animals. Male wild-type (C57BL/6, Jackson Laboratories, Boulder, CO), Aqp4-/-, α-
syntrophin-/-,7 and GLT1-eGFP/NG2-DsRed double-transgenic2 mice at 8-18 weeks of 
age were used in this study. The animals were allowed ad libitum access to food and 
4drinking water. All experiments comply with Norwegian laws and were approved by 
the Animal Care and Use Committee of Institute of Basic Medical Sciences, 
University of Oslo. 
 
Fixation. The animals were deeply anesthetized with a mixture of chloral hydrate, 
magnesium sulphate and pentobarbital (142, 70 and 32 mg/kg body weight i.p., 
respectively) before transcardiac perfusion (flow rate ∼8ml/min) with 2% dextran in 
0.1 M phosphate buffer (PB; pH 7.4) for 15-20 sec and either 4% formaldehyde in PB 
for 15 minutes (for immunofluorescence experiments; 3 GLT1-eGFP/NG2-DsRed 
double-transgenic mice were used), 4% formaldehyde and 0.1% glutaraldehyde in PB 
for 20 minutes (for AQP4 immunogold cytochemistry; 5 wild-type and 5 Aqp4-/- mice 
were used), or bicarbonate-buffered 4% formaldehyde containing 0.2% picric acid at 
pH 6.0, followed by a similar fixative at pH 10.0 (“pH-shift” protocol)3 (for α-
syntrophin immunogold cytochemistry; 5 wild-type, 5 Aqp4-/-, and 3 α-syntrophin-/- 
mice were used) .  
 
Light microscopic immunocytochemistry. The perfused animals were stored at 4o C 
overnight. The brain was removed and cryoprotected in sucrose (10%, 20% and 30% 
in PB), and sections were cut at 15 μm on a cryostat. Light microscopic 
immunocytochemistry was carried out using an indirect fluorescence method.3 The 
primary anti-AQP4 antibody (Sigma, 2μg/ml) was revealed by donkey secondary 
antibodies with indodicarbocyanine (Cy5, Jackson ImmunoResearch Laboratories, 
Inc., West Grove, PA; 1:1,000). Cortical sections were viewed and photographed with 
a Zeiss LSM 5 PASCAL microscope equipped with epifluorescence optics, using 
filter BP 505-530, LP 560 and LP 650, and objective 20X/0.75 Plan-Apochromat, 
540X/1.3 Oil Plan-Neofluar, or 63X/1.40 Oil Plan-Apochromat. 
 
Embedding and electron microscopic cytochemistry. Small blocks of fixed cortex 
were subjected to freeze substitution as described previously.3 In brief, the specimens 
were cryoprotected by immersion in graded concentrations of glycerol (10, 20, and 
30%) in PB and plunged into liquid propane (-170°C) in a cryofixation unit (KF 80; 
Reichert, Wien, Austria). The samples were then immersed in 0.5% uranyl acetate 
dissolved in anhydrous methanol (-90°C) in a cryosubstitution unit (AFS; Reichert). 
The temperature was raised in steps of 4°C /h to -45°C. Samples were washed with 
anhydrous methanol and infiltrated with Lowicryl HM20 resin at -45°C with a 
progressive increase in the ratio of resin to methanol. Polymerization was carried out 
with UV light (360 nm) for 48 h. Ultrathin sections were cut with a Reichert 
ultramicrotome, mounted on nickel grids, and processed for immunogold 
cytochemistry as described previously.3 Briefly, sections were incubated sequentially 
in the following solutions (at room temperature): (1) 50 mM glycine in Tris buffer (5 
mM) containing 0.01% Triton X-100 and 50mM NaCl (TBST; 10 min); (2) 0.2% 
milk powder in TBST (10 min); (3) primary antibodies (AQP4, amino acid residues 
249-323, Milipore, 1.5 μg/ml;  α-syntrophin (Ab Syn259)13, 1.2 μg/ml) diluted in the 
solution used in the preceding step (overnight); (4) same solution as in step 1 (10 min 
x 2); (5) same solution as in step 2 (10 min); (6) gold-conjugated IgG (GAR10 nm; 
Abcam), diluted 1:20 in TBST containing 2% human serum albumin or 0.2% milk 
powder and polyethylene glycol (0.5 mg/ml, 1 h). Finally, the sections were 
counterstained and examined in a Fei Tecnai 12 transmission electron microscope. 
 
Detection and quantification of gold particles. The analyzer was blind to 
6genotypes. Digital images were acquired with a commercially available image 
analysis program ("analySIS" Soft Imaging Systems GmbH, Münster). The program 
had been modified for acquisition of high-resolution digital images and 
semiautomatic evaluation of immunogold-labeled cellular volumes and surfaces 
(membranes). For the present purpose, images of membrane segments were recorded 
at a nominal magnification of x43.000, in 2.048 x 2.048 (8-bit) images. All membrane 
segments that could be identified as belonging to perivascular endfeet of astrocyte 
cells were imaged. Membrane segments of interest were drawn in the overlay and 
assigned a type label. Gold particles in the neighborhood of each membrane-curve 
were detected semiautomatically, and the distance between each particle's centre of 
gravity and its membrane curve was calculated by the program. All images, with 
associated curves, particles, and measurements, were saved to allow later verification 
and correction. Further analyses were done in analySIS. Particles localized within 
23.5 nm from their membrane curve were included in the automated calculation of the 
number of particles per unit length of membrane (linear particle density). The 
measurements were exported to the SPSS 18.0 for Mac software package (SPSS, 
Chicago, IL) for survey and quality control. 
 
Statistical analysis of immunogold data. We used Poisson mixed models for the 
analyses of the gold particle counts in the AQP4 and α-syntrophin data. These models 
take into account the dependency between observations by including nested variance 
terms. Three variance terms were included, one for between animal variation, one for 
between membrane domain variation, and one for within membrane domain variation. 
These models were analysed by the R function glmer in the lme4 package, which 
gave us estimated differences in linear particle density between membrane domains 
7(endfoot membranes facing endothelial cells and pericytes, respectively) with 
corresponding P values. In the AQP4 analysis we allowed the within membrane 
variation to differ between membranes. The chosen model structures were based on 





AQP4 immufluorescence labeling of GLT1-eGFP/NG2-DsRed double-transgenic 
mice, which express fluorescent reporters in astrocytes (Figure 1A) and pericytes 
(Figure 1B), revealed strong AQP4 signal in perivascular astrocytic processes 
adjacent to pericytes (Figure 1C,D).  
Immunogold cytochemistry of wild-type mice confirmed AQP4’s polarized 
distribution, with AQP4 signaling gold particles clustered over astrocytic endfoot 
membranes, in particular where in contact with pericytes (Figure 2A). Quantitative 
analysis revealed that the density of gold particles was 40% higher over membrane 
domains next to pericytes than over those facing endothelial cells (Figure 2B; values 
were 14.20 ± 0.81, n=38, and 10.15 ± 0.67, n=72, respectively). The amount of 
unspecific labeling was revealed in corresponding membranes of Aqp4-/- mice and 
was only 1-2% (values were 0.15 ± 0.04, n= 91, and 0.14 ± 0.11, n=18). 
We next investigated whether the enrichment of AQP4 in specific endfoot 
membrane domains was paralleled with increased expression of the AQP4-anchoring 
molecule α-syntrophin. Indeed, α-syntrophin immunogold reactivity was 33% higher 
in membrane domains adjacent to pericytes versus endothelial cells (Figure 2C,D; 
values were 3.22 ± 0.39, n=61, and 2.43 ± 0.16, n= 215, respectively). Deletion of 
8Aqp4 reduced perivascular α-syntrophin labeling, as reported previously,7 but did not 
affect the pattern of α-syntrophin distribution in endfoot domains. Thus, in Aqp4-/- 
mice the α-syntrophin immunogold signal was still 32% higher in endfoot membranes 
next to pericytes than over those next to endothelial cells (Figure 2E,F; values were 
1.49 ± 0.19, n=53, and 1.13 ± 0.09, n=198). The density of gold particles over endfoot 
membranes adjacent to pericytes and endothelial cells in α-syntrophin-/- mice was 0.25 
± 0.12, n=30, and 0.17 ± 0.04, n=146, respectively. Thus, unspecific labeling in the α-





Polarized distribution of membrane proteins is essential for normal function of cells 
and tissues. A hallmark of glia is their polarization,14, 15 with AQP4 being 
concentrated in glial endfoot membranes bordering liquor and paravascular 
compartments.3 Loss of AQP4 from perivascular membranes occurs in epilepsy, 
stroke, brain injury and Alzheimer’s disease, but the mechanisms are poorly 
understood.15 
We now demonstrate that perivascular astrocytic endfoot membranes differ in 
their AQP4 expression. Specifically, the density of water channels is higher in 
membrane domains abutting pericytes than in those facing endothelial cells. Thus, the 
expression of AQP4 not only depends on which compartment the membrane faces, 
but also on the adjacent cell type. 
The enrichment of AQP4 in membrane domains next to pericytes suggests that 
pericytes regulate AQP4 anchoring. Indeed, the AQP4-anchoring molecule α-
9syntrophin was also concentrated in membrane domains adjacent to pericytes. The 
clustering of α-syntrophin in these domains persisted after Aqp4 deletion, indicating 
that pericytes can influence the DAPC independent of AQP4. How pericytes control 
the expression of endfoot scaffolding proteins is unknown, but one possibility is by 
secretion of agrin, which binds α-dystroglycan.15 Altered agrin secretion from 
vascular cells may underlie loss of glial AQP4 polarization in disease.   
 The functional consequences of heterogeneous AQP4 expression along the 
vascular glial sheath are elusive. Brain-blood water diffusion distance is usually 
longer at sites where pericytes are interposed between the glial sheath and endothelial 
cells. It is conceivable that the higher water permeability of glial membranes at such 
sites can partly compensate for the longer diffusion distance. Moreover, the 
enrichment of AQP4 in glial membranes adjacent to pericytes may serve to facilitate 
fluid transport between the paravascular space and the brain parenchyma. Notably, 
CSF recycles into the brain along penetrating arterioles and enters the neuropil by 
AQP4 dependent mechanisms.2 Finally, an intriguing possibility could be that the 
AQP4 supramolecular complex serves important signaling functions and thus are 
targeted to glial membranes adjacent to contractile vascular cells.  
 Platelet-derived growth factor B (PDGF-B) retention motif knockout mice 
lack pericytes and show reduced expression of perivascular AQP4 and α-syntrophin.12 
However, the mutant mice have vascular abnormalities that indirectly could affect 
AQP4 distribution, cf. Introduction. In the present study we have provided evidence 
that pericytes regulate AQP4 anchoring and polarization in normal mice. Our 
discovery that astrocytic processes contacting pericytes are equipped with specialized 
membrane domains adds complexity to the concept of astrocyte polarization and may 
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Figure 1. AQP4 immunofluorescence labeling is concentrated in astrocytic endfeet 
abutting pericytes. Micrographs from parietal cortex of GLT1-eGFP/NG2-DsRed 
double-transgenic mice showing the spatial relationship between astrocytes (A), 
pericytes (B), and AQP4 immunofluorescence labeling (C). (D) Astrocytic cell bodies 
(green arrow) and their perivascular endfeet (green arrowhead) ensheathe pericyte cell 
bodies (red arrow) and processes (red arrowhead). The AQP4 immunofluorescence 
signal appears particularly strong in astrocytic endfeet adjacent to pericyte cell bodies 
and processes. (E) Transverse section of a capillary branch showing distinct AQP4 
immunofluorescence (blue arrowhead) between a pericyte (red arrowhead) and the 
eGFP-filled cytoplasm of an astrocytic endfoot process (green arrowhead), 
corresponding to the endfoot membrane. Scale bars, A-E, 10 μm. 
 
Figure 2. Immunogold labeling of AQP4 and α-syntrophin is concentrated in 
astrocytic endfoot membrane domains abutting pericytes. (A) Electron micrograph 
showing distribution of AQP4 immunogold labeling in parietal cortex of a wild-type 
(WT) mouse. Gold particles signaling AQP4 are clustered over astrocytic endfoot 
membranes, including membrane domains facing endothelial cells (E) and pericytes 
(P, marked red; white and red arrowheads, respectively). (B) Quantitative analysis of 
AQP4 immunogold labeling over astrocytic endfoot membrane domains. The density 
of gold particles over endfoot membranes abutting pericytes (P) is 40% higher than 
over those facing endothelial cells (E). P value is indicated (Poisson mixed models, 
cf. Materials and Methods; see Results for number of observations). (C) Electron 
15
micrograph showing immunogold staining of α-syntrophin of a WT mouse. Labels as 
in (A). (D) Quantitative analysis reveals 33% higher density of α–syntrophin 
signaling gold particles over endfoot domains facing pericytes (P) compared to those 
facing endothelial cells (E). (E) α–Syntrophin immunogold labeling of an Aqp4-/- 
mouse. Labels as in (A). (F) The relative differences in α–syntrophin labeling density 
between endfoot membrane domains is preserved after deletion of Aqp4, being 32% 
higher over membranes facing pericytes than over those facing endothelial cells. 
Scale bars, A, C and E, 200 nm. 
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